<SEC-DOCUMENT>0001104659-23-029645.txt : 20230307
<SEC-HEADER>0001104659-23-029645.hdr.sgml : 20230307
<ACCEPTANCE-DATETIME>20230307171424
ACCESSION NUMBER:		0001104659-23-029645
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230306
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230307
DATE AS OF CHANGE:		20230307

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DoubleVerify Holdings, Inc.
		CENTRAL INDEX KEY:			0001819928
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		IRS NUMBER:				822714562
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40349
		FILM NUMBER:		23713665

	BUSINESS ADDRESS:	
		STREET 1:		462 BROADWAY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-631-2111

	MAIL ADDRESS:	
		STREET 1:		462 BROADWAY
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm237751d3_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dv="http://doubleverify.com/20230306">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_dv_doubleverify.com_20230306 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20230306_20230306 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001819928 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:EntityCentralIndexKey">0001819928</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="dv-20230306.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-03-06to2023-03-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001819928</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-03-06</xbrli:startDate>
        <xbrli:endDate>2023-03-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20230306__20230306_zQSrQgjWnvH1"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of<br />
the Securities Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported): March 7, 2023 (<span id="xdx_90C_edei--DocumentPeriodEndDate_c20230306__20230306_zlbwLkVFeXOc"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 6, 2023</ix:nonNumeric></span>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_908_edei--EntityRegistrantName_c20230306__20230306_z3ieJFnP8yM"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:EntityRegistrantName">DoubleVerify Holdings, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20230306__20230306_zewyoqfsE7w"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityFileNumber_c20230306__20230306_zGzh82b0rxc1"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:EntityFileNumber">001-40349</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityTaxIdentificationNumber_c20230306__20230306_zU7TGNVjP9S9"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:EntityTaxIdentificationNumber">82-2714562</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction of <br />
incorporation)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20230306__20230306_zqhIzgVQYcv"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:EntityAddressAddressLine1">462 Broadway</ix:nonNumeric></span></b></span><b><span style="font-size: 10pt"><br />
<span id="xdx_902_edei--EntityAddressCityOrTown_c20230306__20230306_zJxMAT9h9b12"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20230306__20230306_zwGLW6dgeMX2"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></b></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: center; width: 49%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityAddressPostalZipCode_c20230306__20230306_zi9LvP4HLIwf"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:EntityAddressPostalZipCode">10013</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address of principal executive offices)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_901_edei--CityAreaCode_c20230306__20230306_zuMiICXX3jH9"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:CityAreaCode">212</ix:nonNumeric></span>) <span id="xdx_909_edei--LocalPhoneNumber_c20230306__20230306_zd6FdbbQeA6b"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:LocalPhoneNumber">631-2111</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_909_edei--WrittenCommunications_c20230306__20230306_z8b3VViYwKGe"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span>
Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_90B_edei--SolicitingMaterial_c20230306__20230306_z87TyMMMStuc"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings"><span id="xdx_906_edei--PreCommencementTenderOffer_c20230306__20230306_zwQh5k0ZQHy5"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span>&#8239;Pre-commencement
communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20230306__20230306_ziPUZ8OFbFJl"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span>
Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b)&#160;of the
Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Title of Class</span></b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Trading Symbol</span></b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Name of Each Exchange on Which Registered</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--Security12bTitle_c20230306__20230306_zb7Jr2u51T49"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:Security12bTitle">Common stock, par value $0.001 per share</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_edei--TradingSymbol_c20230306__20230306_zrUrg0LL7Xuj"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" name="dei:TradingSymbol">DV</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SecurityExchangeName_c20230306__20230306_z4HnfQMBwYmf"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Emerging growth company </span><span style="font-family: Wingdings"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20230306__20230306_zadzO50paH31"><ix:nonNumeric contextRef="From2023-03-06to2023-03-06" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-size: 10pt">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; font-weight: bold; width: 1in">Item&#160;8.01.</td>
    <td style="font-size: 10pt; font-weight: bold">Other Events.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">On March&#160;6, 2023, DoubleVerify Holdings,&#160;Inc.
(the &#8220;Company&#8221;), investment funds associated with Providence Equity Partners L.L.C. (the &#8220;Selling Stockholders&#8221;),
and J.P. Morgan Securities LLC and Barclays Capital Inc. (the &#8220;Underwriters&#8221;) entered into an underwriting agreement (the
&#8220;Underwriting Agreement&#8221;) pursuant to which the Selling Stockholders agreed to sell to the Underwriters, and the Underwriters
agreed to purchase from the Selling Stockholders, subject to and upon terms and conditions set forth therein, 12,500,000 shares of the
Company&#8217;s common stock (the &#8220;Common Stock&#8221;). Pursuant to the Underwriting Agreement, the Selling Stockholders granted
the Underwriters a 30-day option to purchase up to an aggregate of 1,875,000 additional shares of Common Stock (the &#8220;Option&#8221;),
which Option was exercised in full on&#160;March&#160;6, 2023. The Company did not receive any proceeds from the sale of shares
in the offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">The foregoing description of the Underwriting
Agreement does not purport to be complete and is qualified in its entirety by reference to the copy thereof, which is filed herewith as
Exhibit&#160;1.1 and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 1in"><b>Item&#160;9.01.</b></td>
    <td><b>Financial Statements and Exhibits.</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-decoration: underline; text-align: justify; width: 13%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Exhibit&#160;Number</span></b></span></td>
    <td style="text-decoration: underline; text-align: justify; width: 87%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Description</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><a href="tm237751d3_ex1-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></a></td>
    <td style="text-align: justify"><a href="tm237751d3_ex1-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement, dated March&#160;6, 2023, among the Company, the selling stockholders named therein and J.P. Morgan Securities LLC and Barclays Capital Inc.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;to this Current Report on Form&#160;8-K in Inline XBRL.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOUBLEVERIFY HOLDINGS,&#160;INC.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="3">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ Andy Grimmig</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 52%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="width: 41%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andy Grimmig</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Legal Officer</span></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March&#160;7, 2023</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2OtJVCvIyKYksQiK63XKKJd2R2e3vkXrLViUaBobhnO8cIUYip6WukeE4LwvYY9PWyiGUeEFGc0bvyFbrFPwt8aqtY2Vc//7AjDyDnpmM5fTkhd760BarFKQMZRLGMUSzNJnBbiOCTs/IXHSFxmlVgzIV7Jha1ugUv4eEvXqRoebdVx2QrSbj48bRIH8gjmQMW3qoJ/HNQlFkIhj1E4ic6d52NXfrqIFFjY3vsgP63+ALHcNJUw== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm237751d3_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Execution Version</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DoubleVerify Holdings,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Common Stock</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0 auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Underwriting Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">March&nbsp;6, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">J.P. Morgan Securities LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barclays Capital Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">c/o</TD><TD STYLE="text-align: justify">J.P. Morgan Securities LLC</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">383 Madison Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">New York, New York 10179</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in">c/o</TD><TD STYLE="text-align: justify">Barclays Capital Inc.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">745 Seventh Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">New York, New York 10019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Providence VII U.S. Holdings
L.P., a Delaware limited partnership (&ldquo;Providence VII&rdquo;) and Providence Butternut Co-Investment L.P., a Cayman Islands exempted
limited partnership (together with Providence VII, the &ldquo;Selling Stockholders&rdquo;), propose, subject to the terms and conditions
stated in this agreement (this &ldquo;Agreement&rdquo;), to sell to J.P. Morgan Securities LLC and Barclays Capital Inc. (collectively,
the &ldquo;Underwriters&rdquo;) an aggregate of 12,500,000 shares of Common Stock, par value $0.001 per share (&ldquo;Stock&rdquo;), of
DoubleVerify Holdings,&nbsp;Inc., a Delaware corporation (the &ldquo;Company&rdquo;), and, at the election of the Underwriters, up to
1,875,000 additional shares of Stock. The aggregate of 12,500,000 shares of Stock to be sold by the Selling Stockholders is herein called
the &quot;Firm Shares&quot; and the aggregate of 1,875,000 additional shares of Stock to be sold by the Selling Stockholders is herein
called the &ldquo;Optional Shares&rdquo;. The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to
Section&nbsp;2 hereof are herein collectively called the &quot;Shares&quot;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company represents and warrants to, and agrees with, each of the Underwriters that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;An
 &ldquo;automatic shelf registration statement&rdquo; as defined under Rule&nbsp;405 under the Securities Act of 1933, as amended (the
 &ldquo;Act&rdquo;), on Form&nbsp;S-3 (File No.&nbsp;333-267676) in respect of the Shares has been filed with the Securities and Exchange
Commission (the &quot;Commission&quot;) not earlier than three years prior to the date hereof; such registration statement, and any post-effective
amendment thereto, became effective on filing; and no stop order suspending the effectiveness of such registration statement or any part
thereof has been initiated or, to the knowledge of the Company, threatened by the Commission, and no notice of objection of the Commission
to the use of such registration statement or any post-effective amendment thereto pursuant to Rule&nbsp;401(g)(2)&nbsp;under the Act has
been received by the Company (the base prospectus filed as part of such registration statement, in the form in which it has most recently
been filed with the Commission on or prior to the date of this Agreement, is hereinafter called the &ldquo;Basic Prospectus&rdquo;; any
preliminary prospectus (including any preliminary prospectus supplement) relating to the Shares filed with the Commission pursuant to
Rule&nbsp;424(b)&nbsp;under the Act is hereinafter called a &ldquo;Preliminary Prospectus&rdquo;; the various parts of such registration
statement, including all exhibits thereto and including any prospectus supplement relating to the Shares that is filed with the Commission
and deemed by virtue of Rule&nbsp;430B to be part of such registration statement, each as amended at the time such part of the registration
statement became effective, are hereinafter collectively called the &ldquo;Registration Statement&rdquo;; the Basic Prospectus, as amended
and supplemented immediately prior to the Applicable Time (as defined in Section&nbsp;1(a)(iii)&nbsp;hereof), is hereinafter called the
 &ldquo;Pricing Prospectus&rdquo;; the form of the final prospectus relating to the Shares filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;under
the Act in accordance with Section&nbsp;5(a)&nbsp;hereof is hereinafter called the &ldquo;Prospectus&rdquo;; any reference herein to the
Basic Prospectus, the Pricing Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents
incorporated by reference therein pursuant to Item 12 of Form&nbsp;S-3 under the Act, as of the date of such prospectus; any reference
to any amendment or supplement to the Basic Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include
any post-effective amendment to the Registration Statement, any prospectus supplement relating to the Shares filed with the Commission
pursuant to Rule&nbsp;424(b)&nbsp;under the Act and any documents filed under the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), and incorporated by reference therein, in each case after the date of the Basic Prospectus, such Preliminary Prospectus,
or the Prospectus, as the case may be; any reference to any amendment to the Registration Statement shall be deemed to refer to and include
any annual report of the Company filed pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Exchange Act after the effective date
of the Registration Statement that is incorporated by reference in the Registration Statement; and any &ldquo;issuer free writing prospectus&rdquo;
as defined in Rule&nbsp;433 under the Act relating to the Shares is hereinafter called an &ldquo;Issuer Free Writing Prospectus&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(A)&nbsp;No
order preventing or suspending the use of any Preliminary Prospectus or any Issuer Free Writing Prospectus has been issued by the Commission,
and no proceeding for that purpose or pursuant to Section&nbsp;8A of the Act against the Company or related to the offering of the Shares
has been initiated or, to the knowledge of the Company, threatened by the Commission, and (B)&nbsp;each Preliminary Prospectus, at the
time of filing thereof, conformed in all material respects to the requirements of the Act and the rules&nbsp;and regulations of the Commission
thereunder, and did not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however,
that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with any
Underwriter Information (as defined in Section&nbsp;9(c)&nbsp;of this Agreement) or any Selling Stockholder Information (as defined in
Section&nbsp;1(b)(vii)&nbsp;of this Agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;For
the purposes of this Agreement, the &quot;Applicable Time&quot; is 9:00 a.m.&nbsp;(Eastern time) on the date of this Agreement; the Pricing
Prospectus, as supplemented by the information listed on Schedule&nbsp;III(c)&nbsp;hereto, taken together (collectively, the &quot;Pricing
Disclosure Package&quot;), as of the Applicable Time, did not, and as of each Time of Delivery (as defined in Section&nbsp;4(a)&nbsp;of
this Agreement) will not, include any untrue statement of a material fact or omit to state any material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading; and each Issuer Free Writing Prospectus
does not conflict with the information contained in the Registration Statement, the Pricing Prospectus or the Prospectus, and each Issuer
Free Writing Prospectus, as supplemented by and taken together with the Pricing Disclosure Package, as of the Applicable Time, did not,
and as of each Time of Delivery, will not, include any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however,
that this representation and warranty shall not apply to statements or omissions made in reliance upon and in conformity with any Underwriter
Information or any Selling Stockholder Information;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
documents incorporated by reference in the Pricing Prospectus and the Prospectus, when they became effective or were filed with the Commission,
as the case may be, conformed in all material respects to the requirements of the Act or the Exchange Act, as applicable, and the rules&nbsp;and
regulations of the Commission thereunder, and none of such documents contained an untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary to make the statements therein not misleading; any further documents so filed
and incorporated by reference in the Prospectus or any further amendment or supplement thereto, when such documents become effective or
are filed with the Commission, as the case may be, will conform in all material respects to the requirements of the Act or the Exchange
Act, as applicable, and the rules&nbsp;and regulations of the Commission thereunder and will not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; provided,
however, that this representation and warranty shall not apply to statements or omissions made in reliance upon and in conformity with
any Underwriter Information or any Selling Stockholder Information; and no such documents were filed with the Commission since the Commission&rsquo;s
close of business on the business day immediately prior to the date of this Agreement and prior to the execution of this Agreement, except
as set forth on Schedule III(b)&nbsp;hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Registration Statement conforms, and the Prospectus and any further amendments or supplements to the Registration Statement and the Prospectus
will conform, in all material respects to the requirements of the Act and the rules&nbsp;and regulations of the Commission thereunder
and do not and will not, as of the applicable effective date as to each part of the Registration Statement, as of the applicable filing
date as to the Prospectus and any amendment or supplement thereto, and as of each Time of Delivery, contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; provided,
however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity
with any Underwriter Information or any Selling Stockholder Information;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
the Company nor any of its subsidiaries has, since the date of the latest audited financial statements included or incorporated by reference
in the Pricing Prospectus, (i)&nbsp;sustained any material loss or interference with its business from fire, explosion, flood or other
calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree or (ii)&nbsp;entered
into any transaction or agreement (whether or not in the ordinary course of business) that is material to the Company and its subsidiaries
taken as a whole or incurred any liability or obligation, direct or contingent, that is material to the Company and its subsidiaries taken
as a whole, in each case otherwise than as set forth or contemplated in the Pricing Prospectus; and, since the respective dates as of
which information is given in the Registration Statement and the Pricing Prospectus, there has not been (x)&nbsp;any change in the capital
stock (other than as a result of (i)&nbsp;the exercise, if any, of stock options, the settlement, if any, of restricted stock units, or
the award, if any, of stock options, restricted stock units or restricted stock or other awards pursuant to the Company&rsquo;s equity
plans that are described in the Pricing Prospectus and the Prospectus, (ii)&nbsp;the issuance, if any, of Stock upon exercise or conversion
of Company securities as described in the Pricing Prospectus and the Prospectus or (iii)&nbsp;as otherwise set forth or contemplated in
the Pricing Prospectus and the Prospectus), or any increase in long-term debt of the Company or any of its subsidiaries or (y)&nbsp;any
Material Adverse Effect (as defined below); as used in this Agreement, &ldquo;Material Adverse Effect&rdquo; shall mean any material adverse
change or effect, or any development involving a prospective material adverse change or effect, in or affecting (i)&nbsp;the business,
properties, general affairs, management, financial position, stockholders' equity or results of operations of the Company and its subsidiaries,
taken as a whole, except as set forth or contemplated in the Pricing Prospectus, or (ii)&nbsp;the ability of the Company to perform its
obligations under this Agreement or to consummate the transactions contemplated in the Pricing Prospectus and the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and its subsidiaries do not own any real property. The Company and its subsidiaries have good and marketable title to all personal
property owned by them, in each case free and clear of all liens, encumbrances and defects except such as are described in the Pricing
Prospectus and the Prospectus or such as do not materially affect the value of such property and do not materially interfere with the
use made of such property by the Company and its subsidiaries; and any real property and buildings held under lease by the Company and
its subsidiaries are held by them, to the Company&rsquo;s knowledge, under valid, subsisting and enforceable leases (subject to the effects
of (i)&nbsp;bankruptcy, insolvency, fraudulent conveyance, fraudulent transfer, reorganization, moratorium or other similar laws relating
to or affecting the rights or remedies of creditors generally; (ii)&nbsp;the application of general principles of equity (including without
limitation, concepts of materiality, reasonableness, good faith and fair dealing, regardless of whether enforcement is considered in proceedings
at law or in equity); and (iii)&nbsp;applicable law and public policy with respect to rights to indemnity and contribution) with such
exceptions as are not material and do not materially interfere with the use made and proposed to be made of such property and buildings
by the Company and its subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
of the Company and each significant subsidiary (as such term is defined in Rule&nbsp;1-02 of Regulation S-X promulgated under the Act)
of the Company (each, a &ldquo;Significant Subsidiary&rdquo;) has been (i)&nbsp;duly incorporated or organized and is validly existing
and in good standing under the laws of its jurisdiction of incorporation or organization, with power and authority (corporate or other)
to own its properties and conduct its business as described in the Pricing Prospectus, and (ii)&nbsp;duly qualified as a foreign corporation
for the transaction of business and is in good standing (where such concept exists) under the laws of each other jurisdiction in which
it owns or leases properties or conducts any business so as to require such qualification, except, in the case of clause (i)&nbsp;with
respect to each Significant Subsidiary and clause (ii)&nbsp;with respect to each of the Company and each Significant Subsidiary, where
the failure to be so qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has an authorized capitalization as set forth in the Pricing Prospectus and all of the issued shares of capital stock of the Company<B>,
</B>including the Shares to be sold by the Selling Stockholders, have been duly authorized and validly issued and are fully paid and non-assessable
and conform in all material respects to the description thereof contained in the Pricing Disclosure Package and the Prospectus; all of
the issued shares of capital stock of each Significant Subsidiary of the Company have been duly authorized and validly issued, are fully
paid and non-assessable, were not issued in violation of any preemptive or similar rights and (except, in the case of any foreign Significant
Subsidiary, for directors&rsquo; qualifying shares) are owned directly or indirectly by the Company, free and clear of all liens, encumbrances,
equities or claims, except for such liens or encumbrances described in the Pricing Prospectus and the Prospectus. With respect to the
stock options and other equity awards (collectively, the &ldquo;Stock Options&rdquo;) granted pursuant to the stock-based compensation
plans of the Company and its subsidiaries (the &ldquo;Company Stock Plans&rdquo;), (i)&nbsp;each Stock Option intended to qualify as an
 &ldquo;incentive stock option&rdquo; under Section&nbsp;422 of the Code so qualifies, except as would not reasonably be expected to have
a Material Adverse Effect, (ii)&nbsp;each grant of a Stock Option was duly authorized no later than the date on which the grant of such
Stock Option was by its terms to be effective (the &ldquo;Grant Date&rdquo;) by all necessary corporate action, including, as applicable,
approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder
approval by the necessary number of votes or written consents, and, to the knowledge of the Company (other than with respect to the execution
and delivery by the Company), the award agreement governing such grant (if any) was duly executed and delivered by each party thereto,
(iii)&nbsp;each grant of a Stock Option was made, in all material respects, in accordance with the terms of the Company Stock Plans and
applicable law and (iv)&nbsp;each Stock Option was properly accounted for in accordance with U.S. generally accepted accounting principles
(&ldquo;GAAP&rdquo;) in the financial statements (including the related notes) of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
performance by the Company of its obligations under this Agreement and the consummation of the transactions contemplated hereby will not
(A)&nbsp;conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture,
mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party
or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries
is subject, (B)&nbsp;violate any provision of the certificate of incorporation or by-laws (or similar organizational document) of the
Company or any of its Subsidiaries, or (C)&nbsp;violate any statute or any judgment, order, rule&nbsp;or regulation of any court or governmental
agency or body having jurisdiction over the Company or any of its Subsidiaries, except, in the case of clauses (A)&nbsp;and (C), for such
conflicts, defaults, breaches or violations that would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect; and no consent, approval, authorization, order, registration or qualification of or with any such court or governmental
agency or body is required for the sale of the Shares or the consummation by the Company of the transactions contemplated by this Agreement,
except such as have been obtained under the Act, the approval by the Financial Industry Regulatory Authority (&quot;FINRA&quot;) of the
underwriting terms and arrangements, the approval for listing on the Exchange (defined below) and such consents, approvals, authorizations,
orders, registrations or qualifications as may have been obtained or as may be required under state securities or Blue Sky laws in connection
with the purchase and distribution of the Shares by the Underwriters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
the Company nor any of its subsidiaries is (i)&nbsp;in violation of its certificate of incorporation or by-laws (or similar organizational
document), (ii)&nbsp;in violation of any statute or any judgment, order, rule&nbsp;or regulation of any court or governmental agency or
body having jurisdiction over the Company or any of its subsidiaries or any of their properties, or (iii)&nbsp;in default in the performance
or observance of any obligation, agreement, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement,
lease or other agreement or instrument to which it is a party or by which it or any of its properties is bound, except, in the case of
the foregoing clauses (ii)&nbsp;and (iii), for such violations or defaults that would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
statements set forth in the Pricing Prospectus and the Prospectus under the caption &quot;Description of Capital Stock&quot;, insofar
as they purport to constitute a summary of the terms of the Stock, under the caption &quot;Certain U.S. Federal Income Tax Considerations
for Non-U.S. Holders&quot;, and under the caption &quot;Underwriting&quot;, insofar as they purport to describe the provisions of the
laws and documents referred to therein, are accurate summaries of such laws and documents in all material respects; provided, however,
that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with any
Underwriter Information;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xiii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Other
than as set forth in the Pricing Prospectus, there are no legal or governmental proceedings pending to which the Company or any of its
subsidiaries or, to the Company&rsquo;s knowledge, any officer or director of the Company is a party or of which any property of the Company
or any of its subsidiaries is the subject which, if determined adversely to the Company or any of its subsidiaries, would, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect; and, to the Company's knowledge, no such proceedings are
threatened by governmental authorities or others;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xiv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company is not required to be registered as an &quot;investment company&quot;, as such term is defined in the Investment Company Act of
1940, as amended (the &quot;Investment Company Act&quot;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(A)&nbsp;(1)&nbsp;At
the time of filing the Registration Statement, (2)&nbsp;at the time of the most recent amendment thereto for the purposes of complying
with Section&nbsp;10(a)(3)&nbsp;of the Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant
to Section&nbsp;13 or 15(d)&nbsp;of the Exchange Act or form of prospectus), and (3)&nbsp;at the time the Company or any person acting
on its behalf (within the meaning, for this clause only, of Rule&nbsp;163(c)&nbsp;under the Act) made any offer relating to the Shares
in reliance on the exemption of Rule&nbsp;163 under the Act, the Company was a &ldquo;well-known seasoned issuer&rdquo; as defined in
Rule&nbsp;405 under the Act; and (B)&nbsp;at the earliest time after the filing of the Registration Statement that the Company or another
offering participant made a bona fide offer (within the meaning of Rule&nbsp;164(h)(2)&nbsp;under the Act) of the Shares, and at the
date hereof, the Company was not and is not an &ldquo;ineligible issuer&rdquo; as defined in Rule&nbsp;405 under the Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xvi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Deloitte&nbsp;&amp;
Touche LLP, who has certified certain financial statements of the Company and its subsidiaries, is an independent registered public accounting
firm as required by the Act and the rules&nbsp;and regulations of the Commission thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xvii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company maintains a system of internal control over financial reporting (as such term is defined in Rule&nbsp;13a-15(f)&nbsp;under the
Exchange Act) that (i)&nbsp;complies with the requirements of the Exchange Act applicable to the Company, (ii)&nbsp;has been designed
by, or under the supervision of, the Company's principal executive officer and principal financial officer<B>,</B> to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with GAAP and (iii)&nbsp;is designed to provide reasonable assurance that (A)&nbsp;transactions are executed in accordance with management&rsquo;s
general or specific authorization, (B)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity
with GAAP and to maintain accountability for assets, (C)&nbsp;access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, (D)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences and (E)&nbsp;interactive data in eXtensible Business Reporting
Language included or incorporated by reference in the Registration Statement fairly presents the information called for in all material
respects; and except as disclosed in the Pricing Prospectus, the Company is not aware of any material weaknesses in its internal control
over financial reporting (it being understood that this paragraph shall not require the Company to comply with Section&nbsp;404 of the
Sarbanes-Oxley Act of 2002, as amended (the &ldquo;Sarbanes-Oxley Act&rdquo;), as of an earlier date than it would otherwise be required
to so comply under applicable law);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xviii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Since
the date of the latest audited financial statements included or incorporated by reference in the Pricing Prospectus, there has been no
change in the Company's internal control over financial reporting that has materially and adversely affected, or is reasonably likely
to materially and adversely affect, the Company's internal control over financial reporting;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company maintains disclosure controls and procedures (as such term is defined in Rule&nbsp;13a-15(e)&nbsp;under the Exchange Act) that
have been designed to comply with the requirements of the Exchange Act applicable to the Company; such disclosure controls and procedures
have been designed to ensure that material information relating to the Company and its subsidiaries is made known to the Company's principal
executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xx)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has all requisite corporate or other power and authority to execute and deliver this Agreement and to perform its obligations
hereunder; and this Agreement has been duly authorized, executed and delivered by or on behalf of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
the Company nor any of its subsidiaries, nor, to the knowledge of the Company, any director, officer, employee, agent or affiliate of
the Company or any of its subsidiaries has (i)&nbsp;made, offered, promised or authorized any unlawful contribution, gift, entertainment
or other unlawful expense; (ii)&nbsp;made, offered, promised or authorized any direct or indirect unlawful payment to any foreign or
domestic government official or employee, including of any government-owned or controlled entity or of a public international organization,
or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate
for political office; (iii)&nbsp;violated or is in violation of any provision of the Foreign Corrupt Practices Act of 1977, as amended,
or the rules&nbsp;and regulations thereunder, the Bribery Act 2010 of the United Kingdom or any other applicable anti-corruption or anti-bribery
law, statute or regulation (collectively, &ldquo;Anti-Corruption Laws&rdquo;); or (iv)&nbsp;made, offered, agreed, requested or taken
an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment,
kickback or other unlawful or improper payment or benefit; the Company and its subsidiaries have conducted their businesses in compliance
with Anti-Corruption Laws and have instituted and maintained and will continue to maintain policies and procedures designed to promote
and achieve compliance with such laws and with the representations and warranties contained herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
operations of the Company and its subsidiaries are and have been conducted at all times in compliance with the requirements of applicable
anti-money laundering laws, including, but not limited to, the Bank Secrecy Act of 1970, as amended by the USA PATRIOT ACT of 2001, and
the rules&nbsp;and regulations promulgated thereunder, and the anti-money laundering laws of the various jurisdictions in which the Company
and its subsidiaries conduct business (collectively, the &ldquo;Money Laundering Laws&rdquo;) and no action, suit or proceeding by or
before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect
to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxiii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
the Company nor any of its subsidiaries, nor, to the knowledge of the Company, any director, officer, employee, agent or affiliate of
the Company or any of its subsidiaries, is (i)&nbsp;currently the subject or the target of any sanctions administered or enforced by the
U.S. Government, including, without limitation, the Office of Foreign Assets Control of the U.S. Department of the Treasury (&ldquo;OFAC&rdquo;),
or the U.S. Department of State and including, without limitation, the designation as a &ldquo;specially designated national&rdquo; or
 &ldquo;blocked person;&rdquo; the European Union; HM Treasury; or the United Nations Security Council, or other relevant sanctions authority
(collectively, &ldquo;Sanctions&rdquo;); or (ii)&nbsp;located, organized, or resident in a country or territory that is the subject or
target of comprehensive Sanctions broadly prohibiting dealings with that country or territory, including, without limitation, the Crimea,
Donetsk People&rsquo;s Republic, Kherson, Luhansk People&rsquo;s Republic, and Zaporizhzhia regions of Ukraine, Cuba,&nbsp;Iran, North
Korea and Syria (a &ldquo;Sanctioned Jurisdiction&rdquo;). Neither the Company nor any of its subsidiaries is knowingly engaged in, or
has, at any time in the past five years, knowingly engaged in, any dealings or transactions with or involving any individual or entity
that was or is, as applicable, at the time of such dealing or transaction, the subject or target of Sanctions or with any Sanctioned Jurisdiction,
in each case, in violation of Sanctions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxiv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
financial statements included or incorporated by reference in the Registration Statement, the Pricing Prospectus and the Prospectus, together
with the related schedules and notes, present fairly in all material respects the financial position of the Company and its subsidiaries
at the dates indicated and the statement of operations, stockholders&rsquo; equity and cash flows of the Company and its subsidiaries
for the periods specified; said financial statements have been prepared in accordance with GAAP applied on a consistent basis throughout
the periods presented, except as may be expressly stated in the notes thereto. The supporting schedules, if any, included or incorporated
by reference in the Registration Statement present fairly in all material respects and in accordance with GAAP the information required
to be stated therein. Except as included or incorporated by reference therein, no historical or pro forma financial statements or supporting
schedules are required to be included or incorporated by reference in the Registration Statement, the Pricing Prospectus or the Prospectus
under the Act or the rules&nbsp;and regulations promulgated thereunder. All disclosures contained in the Registration Statement, the Pricing
Prospectus and the Prospectus regarding &ldquo;non-GAAP financial measures&rdquo; (as such term is defined by the rules&nbsp;and regulations
of the Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the Act, to
the extent applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
as would not reasonably be expected to have a Material Adverse Effect, the Company and its subsidiaries (i)&nbsp;own or possess adequate
rights to use all patents, patent applications, trademarks, service marks, trade names, domain names, other source indicators and registrations
and applications thereof, copyrights and registrations and applications thereof, copyrightable works, licenses, software, systems and
technology (including trade secrets, know how, methods, processes and other unpatented and/or unpatentable proprietary or confidential
information, systems or procedures and other intellectual property) (collectively, &ldquo;Intellectual Property&rdquo;) owned or used
by the Company and its subsidiaries in the conduct of their respective businesses as currently conducted, in each case as described in
the Prospectus (the &ldquo;Company Intellectual Property&rdquo;), (ii)&nbsp;do not, through the conduct of their respective businesses,
infringe, violate, misappropriate or conflict with any Intellectual Property right of any third party and (iii)&nbsp;have not received
any written notice of any claim of infringement, violation, misappropriation or conflict with, any Intellectual Property rights of any
third party. Neither the Company nor any of its subsidiaries has used, conveyed or distributed any software or other materials distributed
under a &ldquo;free,&rdquo; &ldquo;copyleft,&rdquo; &ldquo;open source,&rdquo; or similar licensing model (&ldquo;Open Source Materials&rdquo;)
in a manner that requires or has required as a result of such use, conveyance or distribution (x)&nbsp;the Company or any of its subsidiaries
to permit reverse-engineering of any products or services of, or any software code or other technology owned by, the Company or any of
its subsidiaries; or (y)&nbsp;any products or services of the Company or any of its subsidiaries, or any software code or other technology
owned by the Company or any of its subsidiaries, to be (A)&nbsp;disclosed or distributed in source code form, (B)&nbsp;licensed for the
purpose of making derivative works or (C)&nbsp;redistributable at no charge, except, in the case of each of the preceding (x)&nbsp;and
(y), such as would not be reasonably expected to have a Material Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxvi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Except
as would not reasonably be expected to have a Material Adverse Effect, the information technology systems, equipment, and software used
by the Company and its subsidiaries in the operation of or necessary for the conduct of their respective businesses as currently conducted
(collectively, &ldquo;IT Systems&rdquo;) (i)&nbsp;operate and perform as required in connection with the operation of the business of
the Company and its subsidiaries as currently conducted, (ii)&nbsp;have not malfunctioned or failed since the Company&rsquo;s inception,
and (iii)&nbsp;are free and clear of all bugs, errors, defects, &ldquo;Trojan horses,&rdquo; &ldquo;time bombs,&rdquo; &ldquo;back doors,&rdquo;
 &ldquo;drop dead devices,&rdquo; malware and other corruptants, including software or hardware components that are designed to interrupt
use of, permit unauthorized access to or disable, damage or erase the IT Systems or the data stored thereon or processed thereby. Except
as would not reasonably be expected to have a Material Adverse Effect, (i)&nbsp;the Company and its subsidiaries currently operate their
respective businesses in a manner compliant with all privacy, data security and data protection laws and regulations and contractual obligations
applicable to the Company&rsquo;s and its subsidiaries&rsquo; collection, processing, usage, transmission, disclosure, sharing or storage
of all user data and all other information that identifies or relates to a distinct individual or household, including personal, personally
identifiable, sensitive, confidential or regulated data, and there have been no breaches, violations, outages or unauthorized uses of
or access to the IT Systems or the data stored thereon or processed thereby, and (ii)&nbsp;the Company and its subsidiaries have used
reasonable efforts to implement and maintain adequate controls, policies, procedures, and safeguards, backup and disaster recovery technology
to maintain and protect their confidential information and the IT Systems and the data stored thereon or processed thereby, consistent
with applicable laws, regulations and industry standards;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxvii)&#8239;&#8239;&#8239;&#8239;&#8239;(A)&nbsp;Each
employee benefit plan, within the meaning of Section&nbsp;3(3)&nbsp;of the Employee Retirement Income Security Act of 1974, as amended
(&ldquo;ERISA&rdquo;), for which the Company or any member of its &ldquo;Controlled Group&rdquo; (defined as any entity, whether or not
incorporated, that is under common control with the Company within the meaning of Section&nbsp;4001(a)(14) of ERISA or any entity that
is regarded as a single employer with the Company under Section&nbsp;414(b),(c),(m)&nbsp;or (o)&nbsp;of the Internal Revenue Code of 1986,
as amended (the &ldquo;Code&rdquo;)) would have any liability (each, a &ldquo;Plan&rdquo;) has been maintained in compliance with its
terms and the requirements of any applicable statutes, orders, rules&nbsp;and regulations, including but not limited to ERISA and the
Code; (B)&nbsp;no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has occurred
with respect to any Plan, excluding transactions effected pursuant to a statutory or administrative exemption; (C)&nbsp;each Plan that
is intended to be qualified under Section&nbsp;401(a)&nbsp;of the Code is so qualified, and nothing has occurred, whether by action or
by failure to act, which would cause the loss of such qualification; (D)&nbsp;neither the Company nor any member of the Controlled Group
sponsors, maintains, contributes to (or has an obligation to contribute to) or has any liability with respect to (x)&nbsp;an employee
pension benefit plan, within the meaning of Section&nbsp;3(2)&nbsp;of ERISA, subject to Title IV of ERISA or (y)&nbsp;an employee benefit
plan required to be accounted for under Accounting Standards Codification Topic 715-60; and (E)&nbsp;no material increase in the aggregate
amount of contributions required to be made to all Plans by the Company or its Controlled Group affiliates in the current fiscal year
of the Company and its Controlled Group affiliates has occurred or is reasonably likely to occur compared to the amount of such contributions
made in the Company&rsquo;s and its Controlled Group affiliates&rsquo; most recently completed fiscal year; except in each case with respect
to the events or conditions set forth in (A)&nbsp;through (E)&nbsp;hereof, as would not, individually or in the aggregate, have a Material
Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxviii)&#8239;&#8239;&#8239;&#8239;(A)&nbsp;There
are no strikes or other labor disputes against the Company or any of its subsidiaries pending or, to the knowledge of the Company, threatened;
and (B)&nbsp;hours worked by and payment made to employees of the Company or any of its subsidiaries have not been in violation of the
Fair Labor Standards Act or any other applicable laws dealing with such matters, except, in the case of (A)&nbsp;and (B), as would not
reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries
has received any notice of cancellation or termination with respect to any collective bargaining agreement to which it is a party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
statistical and market-related data included or incorporated by reference in the Pricing Prospectus and the Prospectus are based on or
derived from sources that the Company believes to be reliable and accurate in all material respects;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxx)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;There
is and has been no failure on the part of the Company or, to the Company&rsquo;s knowledge, any of the Company&rsquo;s directors or officers,
in their capacities as such, to comply in all material respects with any provision of the Sarbanes Oxley Act of 2002, as amended and the
rules&nbsp;and regulations promulgated in connection therewith (the &ldquo;Sarbanes Oxley Act&rdquo;) with which it is required to comply
as of the date of the first public filing of the Initial Registration Statement and the Applicable Time, as applicable, including Section&nbsp;402
related to loans;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxxi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Neither
the Company nor any of its affiliates has taken or will take, directly or indirectly, any action designed to or that could reasonably
be expected to cause or result in the stabilization or manipulation of the price of the Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxxii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and each of its Subsidiaries have such permits, licenses, approvals, consents and authorizations (&ldquo;Permits&rdquo;) as are
necessary under applicable law to conduct their respective businesses in the manner described in the Registration Statement, the Pricing
Prospectus and the Prospectus, except to the extent that any failure to obtain such Permits would not, individually or in the aggregate,
have a Material Adverse Effect. To the Company&rsquo;s knowledge, neither the Company nor any of its Subsidiaries has received notice
of any proceedings related to the revocation or modification of any such Permits that, individually or in the aggregate, if the subject
of an unfavorable decision, ruling or finding, would have a Material Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxxiii)&#8239;&#8239;&#8239;&#8239;&#8239;Each
of the Company and its subsidiaries has filed all federal, state, local and foreign tax returns required to be filed through the date
hereof, or has properly requested extensions thereof, except where the failure to so file such returns would not, individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect, and has paid all material taxes whether or not shown as due thereon;
and other than tax deficiencies that the Company or any subsidiary is contesting in good faith and for which such entity has provided
adequate reserves, in accordance with GAAP, there is no tax deficiency that has been or could be reasonably be expected to be asserted
against the Company or any of its subsidiaries that would reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxxiv)&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and its subsidiaries are insured against such losses and risks and in such amounts as are, in the Company&rsquo;s reasonable judgment,
appropriate for the respective businesses in which they are currently engaged; and the Company has no reason to believe that it will not
be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from
similar insurers as may be necessary to continue its business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxxv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(A)&nbsp;The
Company and its subsidiaries (i)&nbsp;are in compliance with all applicable federal, state, local and foreign laws and regulations relating
to hazardous or toxic substances or wastes, pollutants or contaminants or to the protection of human health or safety, the environment,
and natural resources (collectively, &ldquo;Environmental Laws&rdquo;); and (ii)&nbsp;have not received written notice of any actual or
potential liability under or relating to or any actual or potential violation of any Environmental Laws, or to any investigation or remediation
of any disposal or release of any hazardous or toxic substances or wastes, pollutants or contaminants; and (B)&nbsp;there are no costs
or liabilities associated with Environmental Laws of or relating to the Company or its subsidiaries; except in the case of any of (A)&nbsp;or
(B)&nbsp;for any failure to comply, or cost or liability, as would not, individually or in the aggregate, have a Material Adverse Effect;
and except as described in each of the Pricing Prospectus and the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxxvi)&#8239;&#8239;&#8239;&#8239;&#8239;[Reserved];
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(xxxvii)&#8239;&#8239;&#8239;&#8239;The
interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly
presents the information called for in all material respects and has been prepared in accordance with the Commission&rsquo;s rules&nbsp;and
guidelines applicable thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
of the Selling Stockholders, severally and not jointly, represents and warrants to, and agrees with, each of the Underwriters and the
Company that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Such
Selling Stockholder has full power and authority to enter into this Agreement and to sell, assign, transfer and deliver the Shares to
be sold by such Selling Stockholder hereunder; and this Agreement has been duly authorized, executed and delivered by such Selling Stockholder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
sale of the Shares to be sold by such Selling Stockholder and the performance by such Selling Stockholder of its obligations under this
Agreement, and the consummation of the transactions herein and therein contemplated, will not (A)&nbsp;conflict with or result in a breach
or violation of any of the terms or provisions of, or constitute a default under, any statute, indenture, mortgage, deed of trust, loan
agreement, lease or other agreement or instrument to which such Selling Stockholder is a party or by which such Selling Stockholder is
bound or to which any of the property or assets of such Selling Stockholder is subject, (B)&nbsp;with respect to each Selling Stockholder
other than a natural person, violate any provision of the certificate of incorporation or by-laws (or similar organizational document)
of such Selling Stockholder or (C)&nbsp;violate any statute or any judgment, order, rule&nbsp;or regulation of any court or governmental
agency or body having jurisdiction over such Selling Stockholder; except, in the case of clauses (A)&nbsp;and (C), for such conflicts,
defaults, breaches or violations that would not, individually or in the aggregate, materially and adversely affect the sale of the Shares
to be sold by such Selling Stockholder and the performance by such Selling Stockholder of any of its obligations under this Agreement;
and no consent, approval, authorization, order, registration or qualification of or with any such court or governmental body or agency
having jurisdiction over such Selling Stockholder is required for the performance by such Selling Stockholder of its obligations under
this Agreement and the consummation by such Selling Stockholder of the transactions contemplated by this Agreement in connection with
the Shares to be sold by such Selling Stockholder hereunder, except as have already been obtained or may be required by FINRA, the Exchange,
the Exchange Act or applicable state securities or Blue Sky laws in connection with the purchase and distribution of the Shares by the
Underwriters, or where the failure to obtain any such consent, approval, authorization, order, registration or qualification would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect or materially and adversely affect the sale
of the Shares to be sold by such Selling Stockholder and the performance by such Selling Stockholder of any of its obligations under this
Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Such
Selling Stockholder has, and immediately prior to each Time of Delivery (as defined in Section&nbsp;4(a)&nbsp;hereof) such Selling Stockholder
will have, valid title to, or a valid &ldquo;security entitlement&rdquo; within the meaning of Section&nbsp;8-501 of the New York Uniform
Commercial Code (&ldquo;UCC&rdquo;) in respect of, the Shares to be sold by such Selling Stockholder hereunder at such Time of Delivery,
free and clear of all liens, encumbrances, equities or claims;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
payment for the Shares to be sold by such Selling Stockholder pursuant to this Agreement, delivery of such Shares, as directed by the
Underwriters, to Cede&nbsp;&amp; Co. (&ldquo;Cede&rdquo;) or such other nominee as may be designated by The Depository Trust Company (&ldquo;DTC&rdquo;),
registration of such Shares in the name of Cede or such other nominee and the crediting of such Shares on the books of DTC to securities
accounts of the Underwriters (assuming that neither DTC nor any such Underwriter has notice of any adverse claim (within the meaning of
Section&nbsp;8-105 of the UCC) to such Shares), (A)&nbsp;DTC shall be a &ldquo;protected purchaser&rdquo; of such Shares within the meaning
of Section&nbsp;8-303 of the UCC, (B)&nbsp;under Section&nbsp;8-501 of the UCC, the Underwriters will acquire a valid security entitlement
in respect of such Shares and (C)&nbsp;no action based on any &ldquo;adverse claim&rdquo;, within the meaning of Section&nbsp;8-102 of
the UCC, to such Shares may be asserted against the Underwriters with respect to such security entitlement; for purposes of this representation,
such Selling Stockholder may assume that when such payment, delivery and crediting occur, (x)&nbsp;such Shares will have been registered
in the name of Cede or another nominee designated by DTC, in each case on the Company&rsquo;s share registry in accordance with its certificate
of incorporation, bylaws and applicable law, (y)&nbsp;DTC will be registered as a &ldquo;clearing corporation&rdquo; within the meaning
of Section&nbsp;8-102 of the UCC and (z)&nbsp;appropriate entries to the accounts of the several Underwriters on the records of DTC will
have been made pursuant to the Section&nbsp;8-501 of the UCC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
or prior to the date of the Pricing Prospectus, such Selling Stockholder has executed and delivered to the Underwriters an agreement substantially
in the form of Annex II hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Such
Selling Stockholder has not taken and will not take, directly or indirectly, any action that is designed to or that has constituted or
could reasonably be expected to cause or result in stabilization or manipulation of the price of the Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the extent that any statements or omissions made in the Registration Statement, any Preliminary Prospectus, the Prospectus or any amendment
or supplement thereto are made in reliance upon and in conformity with written information furnished to the Company by such Selling Stockholder
pursuant to Item 7 of Form&nbsp;S-3 expressly for use therein, which information with respect to any Selling Stockholder is limited to
the name and address of such Selling Stockholder, the number of shares of Stock owned by such Selling Stockholder before and after the
offering contemplated hereby and the other information relating to such Selling Stockholder (other than percentages) that appears in the
table and corresponding footnotes under the caption &ldquo;Selling Stockholders&rdquo; in the Registration Statement, any Preliminary
Prospectus, the Prospectus or any amendment or supplement thereto (such information, the &ldquo;Selling Stockholder Information&rdquo;),
such Registration Statement and Preliminary Prospectus did, and the Prospectus and any further amendments or supplements to the Registration
Statement and the Prospectus will, when they become effective or are filed with the Commission, as the case may be, conform in all material
respects to the requirements of the Act and the rules&nbsp;and regulations of the Commission thereunder and not contain any untrue statement
of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(viii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
the extent that any statements or omissions made in any Issuer Free Writing Prospectus are made in reliance upon and in conformity with
any Selling Stockholder Information, each such Issuer Free Writing Prospectus does not conflict with the information contained in the
Registration Statement, the Pricing Prospectus or the Prospectus, and each such Issuer Free Writing Prospectus, as supplemented by and
taken together with the Pricing Disclosure Package, as of the Applicable Time, did not, and as of each Time of Delivery, will not, include
any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein not misleading;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ix)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In order
to facilitate the Underwriters&rsquo; documentation of their compliance with the reporting and withholding provisions of the Tax Equity
and Fiscal Responsibility Act of 1982 with respect to the transactions herein contemplated, such Selling Stockholder will deliver to you
prior to or at the First Time of Delivery a properly completed and executed United States Treasury Department Form&nbsp;W-9 or W-8, as
applicable (or other applicable form or statement specified by Treasury Department regulations in lieu thereof); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Such
Selling Stockholder will not, directly or indirectly, knowingly use the proceeds of the offering of the Shares hereunder, or lend, contribute
or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, (i)&nbsp;to fund or facilitate
any activities of or business with any person, or in any country or territory, that, at the time of such funding, is the subject or the
target of Sanctions, or in any other manner that will result in a violation by any person (including any person participating in the transaction,
whether as underwriter, advisor, investor or otherwise) of Sanctions, or (ii)&nbsp;in furtherance of an offer, payment, promise to pay,
or authorization of the payment or giving of money, or anything else of value, to any person in violation of any Money Laundering Laws
or any Anti-Corruption Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Subject
to the terms and conditions herein set forth, (a)&nbsp;each of the Selling Stockholders agrees, severally and not jointly, to sell to
each of the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from each of the Selling Stockholders,
at a purchase price per share of $26.50, the number of Firm Shares (to be adjusted by you so as to eliminate fractional shares) determined
by multiplying the aggregate number of Firm Shares to be sold by each of the Selling Stockholders as set forth opposite their respective
names in Schedule II hereto by a fraction, the numerator of which is the aggregate number of Firm Shares to be purchased by such Underwriter
as set forth opposite the name of such Underwriter in Schedule&nbsp;I hereto and the denominator of which is the aggregate number of Firm
Shares to be purchased by all of the Underwriters from all of the Selling Stockholders hereunder and (b)&nbsp;in the event and to the
extent that the Underwriters shall exercise the election to purchase Optional Shares as provided below, the Selling Stockholders, as and
to the extent indicated in Schedule&nbsp;II hereto, agree, severally and not jointly, to sell to each of the Underwriters, and each of
the Underwriters agrees, severally and not jointly, to purchase from the Selling Stockholders, at the purchase price per share set forth
in clause (a)&nbsp;of this Section&nbsp;2 (provided that the purchase price per Optional Share shall be reduced by an amount per share
equal to any dividends or distributions declared by the Company and payable on the Firm Shares but not payable on the Optional Shares),
that portion of the number of Optional Shares as to which such election shall have been exercised (to be adjusted by you so as to eliminate
fractional shares) determined by multiplying such number of Optional Shares by a fraction, the numerator of which is the maximum number
of Optional Shares which such Underwriter is entitled to purchase as set forth opposite the name of such Underwriter in Schedule I hereto
and the denominator of which is the maximum number of Optional Shares that all of the Underwriters are entitled to purchase hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders,
as and to the extent indicated in Schedule&nbsp;II hereto, hereby grant, severally and not jointly, to the Underwriters the right to purchase
at their election up to 1,875,000 Optional Shares at the purchase price per share set forth in the paragraph above, provided that the
purchase price per Optional Share shall be reduced by an amount per share equal to any dividends or distributions declared by the Company
and payable on the Firm Shares but not payable on the Optional Shares. Any such election to purchase Optional Shares shall be made in
proportion to the maximum number of Optional Shares to be sold by the Selling Stockholders as set forth in Schedule II hereto. Any such
election to purchase Optional Shares may be exercised only by written notice from you to the Company and the Selling Stockholders, given
within a period of 30 calendar days after the date of this Agreement and setting forth the aggregate number of Optional Shares to be purchased
and the date on which such Optional Shares are to be delivered, as determined by you but in no event earlier than the First Time of Delivery
(as defined in Section&nbsp;4(a)&nbsp;hereof) or, unless you and the Company and the Selling Stockholders otherwise agree in writing,
earlier than two or later than ten business days after the date of such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
the authorization by you of the release of the Shares, the several Underwriters propose to offer the Shares for sale upon the terms and
conditions set forth in the Pricing Disclosure Package and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(a)&nbsp;The
Shares to be purchased by each Underwriter hereunder, in book-entry form, and in such authorized denominations and registered in such
names as the Underwriters may request upon at least forty-eight hours' prior notice to the Company and the Selling Stockholders shall
be delivered by or on behalf of the Selling Stockholders to the Underwriters, through the facilities of DTC, for the account of such Underwriter,
against payment by or on behalf of such Underwriter of the purchase price therefor by wire transfer of Federal (same-day) funds to the
accounts specified by the Selling Stockholders to the Underwriters at least forty-eight hours in advance. The time and date of such delivery
and payment shall be, with respect to the Firm Shares, 9:30 a.m., New York City time, on March&nbsp;8, 2023 or such other time and date
as the Underwriters and the Selling Stockholders may agree upon in writing, and, with respect to the Optional Shares, 9:30 a.m., New York
City time, on the date specified by the Underwriters in each written notice given by the Underwriters of the Underwriters' election to
purchase such Optional Shares, or such other time and date as the Underwriters and the Selling Stockholders may agree upon in writing.
Such time and date for delivery of the Firm Shares is herein called the &quot;First Time of Delivery&quot;, each such time and date for
delivery of the Optional Shares, if not the First Time of Delivery, is herein called the &quot;Second Time of Delivery&quot;, and each
such time and date for delivery is herein called a &quot;Time of Delivery&quot;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
documents to be delivered at each Time of Delivery by or on behalf of the parties hereto pursuant to Section&nbsp;8 hereof, including
the cross receipt for the Shares and any additional documents requested by the Underwriters pursuant to Section&nbsp;8(k)&nbsp;hereof
will be delivered at the offices of Simpson Thacher&nbsp;&amp; Bartlett LLP, 425 Lexington Avenue, New York, New York 10017, or at such
other location, including remotely via electronic means, as the Underwriters, the Company and the Selling Stockholders may agree upon
in writing (the &quot;Closing Location&quot;), and the Shares will be delivered at the office of DTC or its designated custodian, all
at such Time of Delivery. A meeting will be held at the Closing Location at 4:00 p.m., New York City time, on the New York Business Day
next preceding such Time of Delivery, or such other time and date as the Underwriters, the Company and the Selling Stockholders may agree
upon in writing, at which meeting the final drafts of the documents to be delivered pursuant to the preceding sentence will be available
for review by the parties hereto. For the purposes of this Section&nbsp;4, &quot;New York Business Day&quot; shall mean each Monday, Tuesday,
Wednesday, Thursday and Friday which is not a day on which banking institutions in New York are generally authorized or obligated by law
or executive order to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company agrees with each of the Underwriters:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
prepare the Prospectus in a form approved by you and to file such Prospectus pursuant to Rule&nbsp;424(b)&nbsp;under the Act not later
than the Commission's close of business on the second business day following the execution and delivery of this Agreement; to make no
further amendment or any supplement to the Registration Statement, the Basic Prospectus or the Prospectus prior to the last Time of Delivery
of which you disapprove in writing promptly after reasonable notice thereof; to advise you, promptly after it receives notice thereof,
of the time when any amendment to the Registration Statement has been filed or becomes effective or any amendment or supplement to the
Prospectus has been filed and to furnish you with copies thereof; to file promptly all material required to be filed by the Company with
the Commission pursuant to Rule&nbsp;433(d)&nbsp;under the Act; to file promptly all reports and any definitive proxy or information statements
required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d)&nbsp;of the Exchange Act subsequent
to the date of the Prospectus and for so long as the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule&nbsp;173(a)&nbsp;under
the Act) is required in connection with the offering or sale of the Shares; to advise you, promptly after it receives notice thereof,
of the issuance by the Commission of any stop order or of any order preventing or suspending the use of any Preliminary Prospectus or
other prospectus in respect of the Shares, of any notice of objection of the Commission to the use of the Registration Statement or any
post-effective amendment thereto pursuant to Rule&nbsp;401(g)(2)&nbsp;under the Act, of the suspension of the qualification of the Shares
for offering or sale in any jurisdiction, of the initiation or threatening of any proceeding for any such purpose or pursuant to Section&nbsp;8A
of the Act, or of any request by the Commission for the amending or supplementing of the Registration Statement or the Prospectus or for
additional information; and, in the event of the issuance of any stop order or of any order preventing or suspending the use of any Preliminary
Prospectus or other prospectus or suspending any such qualification, to promptly use its best efforts to obtain the withdrawal of such
order; and in the event of any such issuance of a notice of objection, promptly to take such steps including, without limitation, amending
the Registration Statement or filing a new registration statement, at its own expense, as may be necessary to permit offers and sales
of the Shares by the Underwriters (references herein to the Registration Statement shall include any such amendment or new registration
statement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
required by Rule&nbsp;430B(h)&nbsp;under the Act, to prepare a form of prospectus in a form approved by you and to file such form of prospectus
pursuant to Rule&nbsp;424(b)&nbsp;under the Act not later than may be required by Rule&nbsp;424(b)&nbsp;under the Act; and to make no
further amendment or supplement to such form of prospectus which shall be disapproved by you promptly after reasonable notice thereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
by the third anniversary (the &ldquo;Renewal Deadline&rdquo;) of the initial effective date of the Registration Statement, any of the
Shares remain unsold by the Underwriters, the Company will file, if it has not already done so and is eligible to do so, a new automatic
shelf registration statement relating to the Shares, in a form satisfactory to you. If at the Renewal Deadline the Company is no longer
eligible to file an automatic shelf registration statement, the Company will, if it has not already done so, file a new shelf registration
statement relating to the Shares, in a form satisfactory to you and will use its best efforts to cause such registration statement to
be declared effective within 180 days after the Renewal Deadline. The Company will take all other action necessary or appropriate to permit
the public offering and sale of the Shares to continue as contemplated in the expired registration statement relating to the Shares. References
herein to the Registration Statement shall include such new automatic shelf registration statement or such new shelf registration statement,
as the case may be;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Promptly
from time to time to take such action as you may reasonably request to qualify the Shares for offering and sale under the securities laws
of such jurisdictions as you may reasonably request and to comply with such laws so as to permit the continuance of sales and dealings
therein in such jurisdictions for as long as may be necessary to complete the distribution of the Shares, provided that in connection
therewith the Company shall not be required to qualify as a foreign corporation (where not otherwise required), file a general consent
to service of process in any jurisdiction (where not otherwise required) or subject itself to taxation in any jurisdiction in which it
is not now subject to taxation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
the New York Business Day next succeeding the date of this Agreement (or such later time as may be agreed by the Company and the Underwriters)
and from time to time, to furnish the Underwriters with written and electronic copies of the Prospectus in New York City in such quantities
as you may reasonably request, and, if the delivery of a prospectus (or in lieu thereof, the notice referred to in Rule&nbsp;173(a)&nbsp;under
the Act) is required at any time prior to the expiration of nine months after the time of issue of the Prospectus in connection with the
offering or sale of the Shares and if at such time any event shall have occurred as a result of which the Prospectus as then amended or
supplemented would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made when such Prospectus (or in lieu thereof, the notice referred to
in Rule&nbsp;173(a)&nbsp;under the Act) is delivered, not misleading, or, if for any other reason it shall be necessary during such same
period to amend or supplement the Prospectus in order to comply with the Act, to notify you and upon your request to prepare and furnish
without charge to each Underwriter and to any dealer in securities as many written and electronic copies as you may from time to time
reasonably request of an amended Prospectus or a supplement to the Prospectus which will correct such statement or omission or effect
such compliance; and in case any Underwriter is required to deliver a prospectus (or in lieu thereof, the notice referred to in Rule&nbsp;173(a)&nbsp;under
the Act) in connection with sales of any of the Shares at any time nine months or more after the time of issue of the Prospectus, upon
your request but at the expense of such Underwriter, to prepare and deliver to such Underwriter as many written and electronic copies
as you may request of an amended or supplemented Prospectus complying with Section&nbsp;10(a)(3)&nbsp;of the Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
make generally available to its securityholders as soon as practicable (which may be satisfied by filing with the Commission&rsquo;s Electronic
Data Gathering Analysis and Retrieval System (&ldquo;EDGAR&rdquo;)), but in any event not later than sixteen months after the effective
date of the Registration Statement (as defined in Rule&nbsp;158(c)&nbsp;under the Act), an earnings statement of the Company and its subsidiaries
(which need not be audited) complying with Section&nbsp;11(a)&nbsp;of the Act and the rules&nbsp;and regulations of the Commission thereunder
(including, at the option of the Company, Rule&nbsp;158);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;During
the period beginning from the date hereof and continuing to and including the date that is 45 days after the date of the Prospectus (the
 &quot;Company Lock-Up Period&quot;), not to, without the prior written consent of the Underwriters, (i)&nbsp;offer, sell, contract to
sell, pledge, grant any option to purchase, make any short sale or otherwise transfer or dispose of, directly or indirectly, or file with
or confidentially submit (except for any confidential submission for which the Company provides notice to the Underwriters at least five
business days before the date of the confidential submission) to the Commission a registration statement under the Act relating to, any
securities of the Company that are substantially similar to the Shares, including but not limited to any options or warrants to purchase
shares of Stock or any securities that are convertible into or exchangeable for, or that represent the right to receive, Stock or any
such substantially similar securities, or publicly disclose the intention to make any offer, sale, pledge, disposition or filing or (ii)&nbsp;enter
into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Stock or any
such other securities, whether any such transaction described in clause (i)&nbsp;or (ii)&nbsp;above is to be settled by delivery of Stock
or such other securities, in cash or otherwise; provided, however, that the foregoing restrictions shall not apply to (i)&nbsp;the Shares
to be sold hereunder, (ii)&nbsp;the issuance by the Company of Stock upon the exercise of options or the settlement of restricted stock
units outstanding as of the date of this Agreement or issued after the date of this Agreement pursuant to the Company&rsquo;s equity plans
described in the Pricing Prospectus and Prospectus, or (iii)&nbsp;any issuance or transfer of Stock upon the conversion or exchange of
convertible or exchangeable securities outstanding as of the date of this Agreement disclosed in the Pricing Prospectus and the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
pay the required Commission filing fees relating to the Shares within the time required by Rule&nbsp;456(b)(1)&nbsp;under the Act without
regard to the proviso therein and otherwise in accordance with Rules&nbsp;456(b)&nbsp;and 457(r)&nbsp;under the Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To use its best efforts
to continue to list for trading the Shares on The New York Stock Exchange (the &ldquo;Exchange&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Upon
request of any Underwriter, to furnish, or cause to be furnished, to such Underwriter an electronic version of the Company's trademarks,
servicemarks and/or corporate logo for use on the website, if any, operated by such Underwriter for the purpose of facilitating the on-line
offering of the Shares (the &quot;License&quot;); provided, however, that the License shall be used solely for the purpose described above,
is granted without any fee and may not be assigned or transferred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[Reserved];
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
any Selling Stockholder is not a United States person for U.S. federal income tax purposes, the Company will deliver to each Underwriter
(or its agent), (i)&nbsp;on or before the Closing Date, a certificate with respect to the Company&rsquo;s status as a &ldquo;United States
real property holding corporation,&rdquo; dated no more than thirty (30) days prior to the Closing Date, as described in Treasury Regulations
Sections 1.897-2(h)&nbsp;and 1.1445-2(c)(3)&nbsp;and (ii), within thirty (30) days following the Closing Date, proof of delivery to the
U.S. Internal Revenue Service of the required notice, as described in Treasury Regulations Section&nbsp;1.897-2(h)(2).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.&#8239;&#8239;&#8239;&#8239;(a)&#8239;&#8239;&#8239;&#8239;The
Company represents and agrees that, without the prior consent of the Underwriters, it has not made and will not make any offer relating
to the Shares that would constitute a &quot;free writing prospectus&quot; as defined in Rule&nbsp;405 under the Act; each Selling Stockholder
represents and agrees that, without the prior consent of the Company and the Underwriters, it has not made and will not make any offer
relating to the Shares that would constitute a free writing prospectus; and each Underwriter represents and agrees that, without the prior
consent of the Company and the other Underwriter, it has not made and will not make any offer relating to the Shares that would constitute
a free writing prospectus required to be filed with the Commission; any such free writing prospectus the use of which has been consented
to by the Company and the Underwriters is listed on Schedule III(a)&nbsp;hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company has complied and will comply with the requirements of Rule&nbsp;433 under the Act applicable to any Issuer Free Writing Prospectus,
including timely filing with the Commission or retention where required and legending;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company agrees that if at any time following issuance of an Issuer Free Writing Prospectus any event occurred or occurs as a result of
which such Issuer Free Writing Prospectus would conflict with the information in the Registration Statement, the Pricing Prospectus or
the Prospectus or would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements therein, in the light of the circumstances then prevailing, not misleading, the Company will give prompt notice thereof to
the Underwriters and, if requested by the Underwriters, will prepare and furnish without charge to each Underwriter an Issuer Free Writing
Prospectus or other document which will correct such conflict, statement or omission; provided, however, that this covenant shall not
apply to any statements or omissions in any Issuer Free Writing Prospectus made in reliance upon and in conformity with any Underwriter
Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and each of the Selling Stockholders covenant and agree with one another and with the several Underwriters that (a)&nbsp;the Company
will pay or cause to be paid the following: (i)&nbsp;the fees, disbursements and expenses of the Company's counsel and accountants in
connection with the registration of the Shares under the Act and all other expenses incurred in connection with the preparation, printing,
reproduction and filing of the Registration Statement, any Preliminary Prospectus, any Issuer Free Writing Prospectus and the Prospectus
and amendments and supplements thereto and the mailing and delivering of copies thereof to the Underwriters and dealers; (ii)&nbsp;the
cost of printing or producing this Agreement, the Blue Sky Memorandum, closing documents and any other documents in connection with the
offering, purchase, sale and delivery of the Shares; (iii)&nbsp;all expenses in connection with the qualification of the Shares for offering
and sale under state securities laws as provided in Section&nbsp;5(b)&nbsp;hereof, including the reasonable and documented fees and disbursements
of counsel for the Underwriters in connection with such qualification and in connection with the Blue Sky survey; (iv)&nbsp;all fees and
expenses in connection with listing the Shares on the Exchange, if any; (v)&nbsp;the filing fees incident to, and the reasonable and documented
fees and disbursements of counsel for the Underwriters in connection with, any required review by FINRA of the terms of the sale of the
Shares; provided, however, that the fees and disbursements of counsel for the Underwriters pursuant to clauses (iii)&nbsp;and (v)&nbsp;above
shall not exceed $40,000 in the aggregate; (vi)&nbsp;the cost of preparing stock certificates; if applicable (vii)&nbsp;the cost and charges
of any transfer agent or registrar; and (viii)&nbsp;all other costs and expenses incident to the performance of its obligations hereunder
which are not otherwise specifically provided for in this Section&nbsp;7; and (b)&nbsp;such Selling Stockholder will pay or cause to be
paid all costs, expenses and taxes incident to the performance of such Selling Stockholder's obligations hereunder which are not otherwise
specifically provided for in this Section&nbsp;7, including (i)&nbsp;any fees and expenses of counsel for such Selling Stockholder and
(ii)&nbsp;all expenses and taxes incident to the sale and delivery of the Shares to be sold by such Selling Stockholder to the Underwriters
hereunder. In connection with clause (b)(ii)&nbsp;of the preceding sentence, the Underwriters agree to pay New York State stock transfer
tax, and the Selling Stockholder agrees to reimburse the Underwriters for associated carrying costs if such tax payment is not rebated
on the day of payment and for any portion of such tax payment not rebated. It is understood, however, that the Company shall bear, and
the Selling Stockholders shall not be required to pay or to reimburse the Company for, the cost of any other matters not directly relating
to the sale and purchase of the Shares pursuant to this Agreement, and that, except as provided in this Section&nbsp;7, and Sections 9
and 12 hereof, the Underwriters will pay all of their own costs and expenses, including the fees and disbursements of their counsel, lodging,
travel and meal expenses (including for potential investors) in connection with any roadshow, stock transfer taxes on resale of any of
the Shares by them, and any advertising expenses connected with any offers they may make. The provisions of this Section&nbsp;7 shall
not supersede or otherwise affect any agreement that the Company and the Selling Stockholders may otherwise have with each other for the
allocation of costs, fees and expenses amongst the Company and the Selling Stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
obligations of the Underwriters hereunder, as to the Shares to be delivered at each Time of Delivery, shall be subject, in their discretion,
to the condition that all representations and warranties and other statements of the Company and the Selling Stockholders herein are,
at and as of the Applicable Time and such Time of Delivery, true and correct, the condition that the Company and the Selling Stockholders
shall have performed all of its and their obligations hereunder theretofore to be performed, and the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Prospectus shall have been filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;under the Act within the applicable time period
prescribed for such filing by the rules&nbsp;and regulations under the Act and in accordance with Section&nbsp;5(a)&nbsp;hereof; all material
required to be filed by the Company pursuant to Rule&nbsp;433(d)&nbsp;under the Act shall have been filed with the Commission within the
applicable time period prescribed for such filings by Rule&nbsp;433; no stop order suspending the effectiveness of the Registration Statement
or any part thereof shall have been issued and no proceeding for that purpose shall have been initiated or threatened by the Commission
and no notice of objection of the Commission to the use of the Registration Statement or any post-effective amendment thereto pursuant
to Rule&nbsp;401(g)(2)&nbsp;under the Act shall have been received; no stop order suspending or preventing the use of the Prospectus or
any Issuer Free Writing Prospectus shall have been initiated or threatened by the Commission; and all requests for additional information
on the part of the Commission shall have been complied with to your reasonable satisfaction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Simpson
Thacher&nbsp;&amp; Bartlett LLP, counsel for the Underwriters, shall have furnished to you such written opinion or opinions, dated such
Time of Delivery, in form and substance satisfactory to you, and such counsel shall have received such papers and information as they
may reasonably request to enable them to pass upon such matters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Debevoise&nbsp;&amp;
Plimpton LLP, counsel for the Company and the Selling Stockholders, shall have furnished to you their written opinion or opinions (a form
of such opinion is attached as Annex I(a)&nbsp;hereto), dated such Time of Delivery, in form and substance reasonably satisfactory to
you;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
respective local counsel for each of the Selling Stockholders, as indicated in Schedule II hereto, each shall have furnished to you their
written opinion with respect to each of the Selling Stockholders for whom they are acting as counsel (a form of each such opinion is attached
as Annex&nbsp;I(b)&nbsp;hereto), dated such Time of Delivery, in form and substance reasonably satisfactory to you;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On
the date of the Prospectus at a time prior to the execution of this Agreement, at or around 9:30 a.m., New York City time, on the effective
date of any post-effective amendment to the Registration Statement filed subsequent to the date of this Agreement and also at each Time
of Delivery, Deloitte&nbsp;&amp; Touche LLP shall have furnished to you a letter or letters, dated the respective dates of delivery thereof,
in form and substance reasonably satisfactory to you, containing statements and information of the type ordinarily included in accountants&rsquo;
 &ldquo;comfort letters&rdquo; to the Underwriters with respect to the financial statements and certain financial information contained
in the Registration Statement, the Pricing Disclosure Package and the Prospectus; provided that the letter delivered at each Time of Delivery
shall use a &ldquo;cut-off date&rdquo; not earlier than three business days prior to such Time of Delivery;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(i)&nbsp;Neither
the Company nor any of its subsidiaries shall have sustained since the date of the latest audited financial statements included or incorporated
by reference in the Pricing Prospectus any loss or interference with its business from fire, explosion, flood or other calamity, whether
or not covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth or
contemplated in the Pricing Prospectus, and (ii)&nbsp;since the respective dates as of which information is given in the Pricing Prospectus
there shall not have been any change in the capital stock (other than as a result of (A)&nbsp;the exercise, if any, of stock options,
the settlement, if any, of restricted stock units, or the award, if any, of stock options, restricted stock units or restricted stock
or other awards pursuant to the Company&rsquo;s equity plans that are described in the Pricing Prospectus and the Prospectus, (B)&nbsp;the
issuance, if any, of Stock upon exercise or conversion of Company securities as described in the Pricing Prospectus and the Prospectus
or (C)&nbsp;as otherwise set forth or contemplated in the Pricing Prospectus and the Prospectus), or any increase in long-term debt of
the Company or any of its subsidiaries or any change or effect, or any development involving a prospective change or effect, in or affecting
(x)&nbsp;the business, properties, general affairs, management, financial position, stockholders&rsquo; equity or results of operations
of the Company and its subsidiaries, taken as a whole, except as set forth or contemplated in the Pricing Prospectus, or (y)&nbsp;the
ability of the Company to perform its obligations under this Agreement or to consummate the transactions contemplated in the Pricing Prospectus
and the Prospectus, the effect of which, in any such case described in clause (x)&nbsp;or (y), is in your judgment so material and adverse
as to make it impracticable or inadvisable to proceed with the public offering or the delivery of the Shares being delivered at such Time
of Delivery on the terms and in the manner contemplated in the Pricing Prospectus and the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On or after the Applicable
Time (i)&nbsp;no downgrading shall have occurred in the rating(s), if any, accorded the Company's debt securities or preferred stock by
any &quot;nationally recognized statistical rating organization&quot;, as defined in Section&nbsp;3(a)(62) of the Exchange Act, and (ii)&nbsp;no
such organization shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating(s),
if any, of any of the Company's debt securities or preferred stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;On or after the Applicable
Time there shall not have occurred any of the following: (i)&nbsp;a suspension or material limitation in trading in securities generally
on either the Exchange or The Nasdaq Stock Market; (ii)&nbsp;a suspension or material limitation in trading in the Company's securities
on the Exchange; (iii)&nbsp;a general moratorium on commercial banking activities declared by either Federal or New York State authorities
or a material disruption in commercial banking or securities settlement or clearance services in the United States; (iv)&nbsp;the outbreak
or escalation of hostilities involving the United States or the declaration by the United States of a national emergency or war or (v)&nbsp;the
occurrence of any other calamity or crisis or any change in financial, political or economic conditions in the United States or elsewhere,
if the effect of any such event specified in clause (iv)&nbsp;or (v)&nbsp;in your judgment makes it impracticable or inadvisable to proceed
with the public offering or the delivery of the Shares being delivered at such Time of Delivery on the terms and in the manner contemplated
in the Pricing Prospectus and the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Shares to be sold at such Time of Delivery shall have been duly listed on the Exchange;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall have obtained and delivered to the Underwriters executed copies of an agreement from the Chief Executive Officer, Chief
Financial Officer and any director of the Company designated by one of any of Selling Stockholders or an affiliate thereof and each Selling
Stockholder, substantially to the effect set forth in Annex II hereto in form and substance satisfactory to you;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company shall have complied with the provisions of Section&nbsp;5(c)&nbsp;hereof with respect to the furnishing of prospectuses on the
New York Business Day next succeeding the date of this Agreement (or such later time as may be agreed by the Company and the Underwriters);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and the Selling Stockholders shall have furnished or caused to be furnished to you at such Time of Delivery certificates of officers
of the Company and of the Selling Stockholders, respectively, satisfactory to you as to the accuracy of the representations and warranties
of the Company and the Selling Stockholders, respectively, herein at and as of such Time of Delivery, as to the performance by the Company
and the Selling Stockholders of all of their respective obligations hereunder to be performed at or prior to such Time of Delivery, as
to such other matters as you may reasonably request, and the Company shall have furnished or caused to be furnished certificates as to
the matters set forth in subsections (a)&nbsp;and (f)&nbsp;of this Section&nbsp;8;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Split-Segment; Name: Sp_02 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and each Selling Stockholder shall have delivered to the Underwriters, on or prior to the date of execution of this Agreement,
a properly completed and executed Certification Regarding Beneficial Owners of Legal Entity Customers, together with copies of identifying
documentation, and the Company and each Selling Stockholder undertakes to provide such additional supporting documentation applicable
to it as the Underwriters may reasonably request in connection with the verification of the foregoing certification;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
order to facilitate the Underwriters' documentation of their compliance with the reporting and withholding provisions of the Tax Equity
and Fiscal Responsibility Act of 1982 with respect to the transactions herein contemplated, such Selling Stockholder shall have delivered
to you prior to or at the First Time of Delivery a properly completed and executed United States Treasury Department Form&nbsp;W-9 or
W-8, as applicable (or other applicable form or statement specified by United States Treasury Department regulations in lieu thereof);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and the Selling Stockholders shall have furnished or caused to be furnished to the Underwriters, at such Time of Delivery, such
additional information, certificates, opinions or documents, if any, as are customary for similar transactions and the Underwriters reasonably
request with reasonable advance notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(a)&nbsp;
The Company will indemnify and hold harmless each Underwriter against any losses, claims, damages or liabilities, joint or several, to
which such Underwriter may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions
in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the
Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto,
any Issuer Free Writing Prospectus, any &ldquo;roadshow&rdquo; as defined in Rule&nbsp;433(h)&nbsp;under the Act (a &ldquo;roadshow&rdquo;)
or any &quot;issuer information&quot; filed or required to be filed pursuant to Rule&nbsp;433(d)&nbsp;under the Act (&ldquo;Issuer Information&rdquo;),
or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary
to make the statements therein not misleading, and will reimburse each Underwriter for any legal or other expenses reasonably incurred
by such Underwriter in connection with investigating or defending any such action or claim as such expenses are incurred; provided, however,
that the Company shall not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is
based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, any Preliminary
Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto, any Issuer Free Writing Prospectus or any
roadshow, in reliance upon and in conformity with any Underwriter Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
of the Selling Stockholders, severally and not jointly, will indemnify and hold harmless each Underwriter against any losses, claims,
damages or liabilities, joint or several, to which such Underwriter may become subject, under the Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement
of a material fact contained in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any
amendment or supplement thereto, any Issuer Free Writing Prospectus, any roadshow or any Issuer Information, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements
therein not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or
omission or alleged omission was made in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus,
or any amendment or supplement thereto, any Issuer Free Writing Prospectus, any roadshow or any Issuer Information, in reliance upon and
in conformity with any Selling Stockholder Information relating to such Selling Stockholder; and will reimburse each Underwriter for any
legal or other expenses reasonably incurred by such Underwriter in connection with investigating or defending any such action or claim
as such expenses are incurred; provided, however, that such Selling Stockholder shall not be liable in any such case to the extent that
any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or
alleged omission made in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment
or supplement thereto, any Issuer Free Writing Prospectus, any roadshow or any Issuer Information, in reliance upon and in conformity
with any Underwriter Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
Underwriter, severally and not jointly, will indemnify and hold harmless (i)&nbsp;the Company, its directors, each officer who signed
the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Act or Section&nbsp;20
of the Exchange Act and (ii)&nbsp;each Selling Stockholder and each person, if any, who controls such Selling Stockholder within the meaning
of Section&nbsp;15 of the Act or Section&nbsp;20 of the Exchange Act against any losses, claims, damages or liabilities to which the Company
or such Selling Stockholder may become subject, under the Act or otherwise, insofar as such losses, claims, damages or liabilities (or
actions in respect thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement thereto,
any Issuer Free Writing Prospectus, any roadshow or any Issuer Information, or arise out of or are based upon the omission or alleged
omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, in
each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission
was made in the Registration Statement, any Preliminary Prospectus, the Pricing Prospectus or the Prospectus, or any amendment or supplement
thereto, or any Issuer Free Writing Prospectus, any roadshow or any Issuer Information, in reliance upon and in conformity with any Underwriter
Information; and will reimburse the Company and each Selling Stockholder for any legal or other expenses reasonably incurred by the Company
or such Selling Stockholder in connection with investigating or defending any such action or claim as such expenses are incurred. As used
in this Agreement with respect to an Underwriter and an applicable document, &ldquo;Underwriter Information&rdquo; shall mean the written
information furnished to the Company by such Underwriter expressly for use therein; it being understood and agreed upon that the only
such information furnished by any Underwriter consists of the following information in the Prospectus furnished on behalf of each Underwriter:
the name of each Underwriter, and
the information contained in the fifth, eighth, twelfth and thirteenth paragraphs under the caption &ldquo;Underwriting&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B>Promptly
after receipt by an indemnified party under subsection (a), (b), or (c)&nbsp;of this Section&nbsp;9 of notice of the commencement of any
action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection,
notify the indemnifying party in writing of the commencement thereof; provided that the failure to notify the indemnifying party shall
not relieve it from any liability that it may have under the preceding paragraphs of this Section&nbsp;9 except to the extent that it
has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and provided further that the
failure to notify the indemnifying party shall not relieve it from any liability that it may have to an indemnified party otherwise than
under the preceding paragraphs of this Section&nbsp;9. In case any such action shall be brought against any indemnified party and it shall
notify the indemnifying party of the commencement thereof, the indemnifying party shall be entitled to participate therein and, to the
extent that it shall wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel reasonably
satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying
party), and, after notice from the indemnifying party to such indemnified party of its election so to assume the defense thereof, the
indemnifying party shall not be liable to such indemnified party under such subsection for any legal expenses of other counsel or any
other expenses, in each case subsequently incurred by such indemnified party, in connection with the defense thereof other than reasonable
costs of investigation. In any such proceeding, any indemnified party shall have the right to retain its own counsel, but the fees and
expenses of such counsel shall be at the expense of such indemnified party unless (i)&nbsp;the indemnifying party and the indemnified
party shall have mutually agreed to the contrary; (ii)&nbsp;the indemnifying party has failed within a reasonable time to retain counsel
reasonably satisfactory to the indemnified party; (iii)&nbsp;the indemnified party shall have reasonably concluded that there may be legal
defenses available to it that are different from or in addition to those available to the indemnifying party; or (iv)&nbsp;the named parties
in any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation
of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. No indemnifying
party shall, without the written consent of the indemnified party, effect the settlement or compromise of, or consent to the entry of
any judgment with respect to, any pending or threatened action or claim in respect of which indemnification or contribution may be sought
hereunder (whether or not the indemnified party is an actual or potential party to such action or claim) unless such settlement, compromise
or judgment (i)&nbsp;includes an unconditional release of the indemnified party from all liability arising out of such action or claim
and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified
party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If the indemnification
provided for in this Section&nbsp;9 is unavailable to or insufficient to hold harmless an indemnified party under subsection (a), (b),
or (c)&nbsp;above in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then
each indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims,
damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative benefits received
by the Company and the Selling Stockholders on the one hand and the Underwriters on the other from the offering of the Shares and with
the proportion among the Company and the Selling Stockholders to reflect the relative fault of the Company and the Selling Stockholders.
If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law, then each indemnifying
party shall contribute to such amount paid or payable by such indemnified party in such proportion as is appropriate to reflect not only
such relative benefits but also the relative fault of the Company and the Selling Stockholders on the one hand and the Underwriters on
the other in connection with the statements or omissions which resulted in such losses, claims, damages or liabilities (or actions in
respect thereof), as well as any other relevant equitable considerations and with the proportion among the Company and the Selling Stockholders
to reflect the relative fault of the Company and the Selling Stockholders. The relative benefits received by the Company and the Selling
Stockholders on the one hand and the Underwriters on the other shall be deemed to be in the same proportion as the total net proceeds
from the offering (before deducting expenses) received by the Selling Stockholders as set forth on the cover page&nbsp;of the Prospectus
bear to the actual underwriting spread per Share multiplied by the number of Shares sold pursuant to this Agreement. The relative fault
shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission
or alleged omission to state a material fact relates to information supplied by the Company or the Selling Stockholders on the one hand
or the Underwriters on the other and the parties' relative intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. The Company, each of the Selling Stockholders and the Underwriters agree that it would not be just and equitable
if contribution pursuant to this subsection (e)&nbsp;were determined by pro rata allocation (even if the Selling Stockholders or the
Underwriters, as applicable, were treated as one entity for such purpose) or by any other method of allocation which does not take account
of the equitable considerations referred to above in this subsection (e). The amount paid or payable by an indemnified party as a result
of the losses, claims, damages or liabilities (or actions in respect thereof) referred to above in this subsection (e)&nbsp;shall be
deemed to include any documented legal or other expenses reasonably incurred by such indemnified party in connection with investigating
or defending any such action or claim. Notwithstanding the provisions of this subsection (e), no Underwriter shall be required to contribute
any amount in excess of the amount by which the total price at which the Shares underwritten by it and distributed to the public were
offered to the public exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue
or alleged untrue statement or omission or alleged omission, and no Selling Stockholder shall be required to contribute any amount in
excess of the amount by which the net proceeds after commissions but before offering expenses received by such Selling Stockholder from
the sale of the Shares under this Agreement exceeds any damages which such Selling Stockholder has otherwise been required to pay by
reason of an untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within
the meaning of Section&nbsp;11(f)&nbsp;of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Underwriters' obligations in this subsection (e)&nbsp;to contribute are several in proportion to their respective
underwriting obligations and not joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<B>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B>The
obligations of the Company and the Selling Stockholders under this Section&nbsp;9 shall be in addition to any liability which the Company
and the Selling Stockholders may otherwise have and shall extend, upon the same terms and conditions, to each employee, officer and director
of each Underwriter and each person, if any, who controls any Underwriter within the meaning of the Act and each broker-dealer or other
affiliate of any Underwriter; and the obligations of the Underwriters under this Section&nbsp;9 shall be in addition to any liability
which the respective Underwriters may otherwise have and shall extend, upon the same terms and conditions, to each officer and director
of the Company (including any person who, with his or her consent, is named in the Registration Statement as about to become a director
of the Company) and to each person, if any, who controls the Company or any Selling Stockholder within the meaning of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
any Underwriter shall default in its obligation to purchase the Shares that it has agreed to purchase hereunder at a Time of Delivery,
you may in your discretion arrange for you or another party or other parties to purchase such Shares on the terms contained herein. If
within thirty-six hours after such default by any Underwriter you do not arrange for the purchase of such Shares, then the Selling Stockholders
shall be entitled to a further period of thirty-six hours within which to procure another party or other parties satisfactory to you to
purchase such Shares on such terms. In the event that, within the respective prescribed periods, you notify the Selling Stockholders that
you have so arranged for the purchase of such Shares, or a Selling Stockholder notifies you that it has so arranged for the purchase of
such Shares, you or the Selling Stockholders shall have the right to postpone such Time of Delivery for a period of not more than seven
days, in order to effect whatever changes may thereby be made necessary in the Registration Statement or the Prospectus, or in any other
documents or arrangements, and the Company agrees to file promptly any amendments or supplements to the Registration Statement or the
Prospectus which in your opinion may thereby be made necessary. The term &quot;Underwriter&quot; as used in this Agreement shall include
any person substituted under this Section&nbsp;10 with like effect as if such person had originally been a party to this Agreement with
respect to such Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If,
after giving effect to any arrangements for the purchase of the Shares of any one defaulting Underwriter by you, the Selling Stockholders
as provided in subsection (a)&nbsp;above, the aggregate number of such Shares which remains unpurchased does not exceed one-eleventh of
the aggregate number of all the Shares to be purchased at such Time of Delivery, then the Selling Stockholders shall have the right to
require the non-defaulting Underwriter to purchase the number of Shares which such Underwriter agreed to purchase hereunder at such Time
of Delivery and, in addition, to require the non-defaulting Underwriter to purchase its pro rata share (based on the number of Shares
which such Underwriter agreed to purchase hereunder) of the Shares of such defaulting Underwriter for which such arrangements have not
been made; but nothing herein shall relieve a defaulting Underwriter from liability for its default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If,
after giving effect to any arrangements for the purchase of the Shares of a defaulting Underwriter or Underwriters by you and the Selling
Stockholders as provided in subsection (a)&nbsp;above, the aggregate number of such Shares which remains unpurchased exceeds one-eleventh
of the aggregate number of all of the Shares to be purchased at such Time of Delivery, or if the Selling Stockholders shall not exercise
the right described in subsection (b)&nbsp;above to require the non-defaulting Underwriter to purchase Shares of the defaulting Underwriter,
then this Agreement (or, with respect to a Second Time of Delivery, the obligations of the Underwriters to purchase and of the Selling
Stockholders to sell the Optional Shares) shall thereupon terminate, without liability on the part of any non-defaulting Underwriter or
the Selling Stockholders, except for the expenses to be borne by the Selling Stockholders and the Underwriters as provided in Section&nbsp;7
hereof and the indemnity and contribution agreements in Section&nbsp;9 hereof; but nothing herein shall relieve a defaulting Underwriter
from liability for its default.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
respective indemnities, rights of contribution, agreements, representations, warranties and other statements of the Company, the Selling
Stockholders and the several Underwriters, as set forth in this Agreement or made by or on behalf of them, respectively, pursuant to this
Agreement, shall remain in full force and effect, regardless of any investigation (or any statement as to the results thereof) made by
or on behalf of any Underwriter or any director, officer, employee, affiliate or controlling person of any Underwriter, or the Company,
or any of the Selling Stockholders, or any officer or director or controlling person of the Company, or any controlling person of any
Selling Stockholder, and shall survive delivery of and payment for the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
this Agreement shall be terminated pursuant to Section&nbsp;10 hereof, the Selling Stockholders shall then not be under any liability
to any Underwriter except as provided in Sections 7 and 9 hereof; but, if for any other reason any Shares are not delivered by or on behalf
of the Selling Stockholders as provided herein, or the Underwriters decline to purchase the Shares for any reason permitted under this
Agreement, each of the Selling Stockholders pro rata (based on the number of Shares to be sold by such Selling Stockholder hereunder)
will reimburse the Underwriters through you for all out-of-pocket expenses approved in writing by you, including documented fees and disbursements
of counsel, reasonably incurred by the Underwriters in making preparations for the purchase, sale and delivery of the Shares not so delivered,
but the Company and the Selling Stockholders shall then be under no further liability to any Underwriter except as provided in Sections
7 and 9 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October&nbsp;26, 2001)), the Underwriters
are required to obtain, verify and record information that identifies their respective clients, including the Company and the Selling
Stockholders, which information may include the name and address of their respective clients, as well as other information that will allow
the Underwriters to properly identify their respective clients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All statements, requests,
notices and agreements hereunder shall be in writing, and if to the Underwriters shall be delivered or sent by mail, telex or facsimile
transmission to J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention: Equity Syndicate Desk and to Barclays
745 Seventh Avenue, New York, New York 10019, Attention: Syndicate Registration, Fax: 646-834-8133; if to any Selling Stockholder shall
be delivered or sent by mail, telex or facsimile transmission to counsel for such Selling Stockholder at its address set forth in Schedule
II hereto; if to the Company shall be delivered or sent by mail, telex or facsimile transmission to the address of the Company set forth
on the cover of the Registration Statement, Attention: Chief Legal Officer, with a copy to Morgan J. Hayes, Debevoise&nbsp;&amp; Plimpton
LLP, 919 Third Avenue, New York, New York 10022; and if to any stockholder that has delivered a lock-up letter described in Section&nbsp;8(j)&nbsp;hereof
shall be delivered or sent by mail to his or her respective address as such stockholder provides in writing to the Company; provided,
however, that any notice to an Underwriter pursuant to Section&nbsp;9(d)&nbsp;hereof shall be delivered or sent by mail, telex or facsimile
transmission to such Underwriter at its address set forth in its Underwriters&rsquo; Questionnaire or telex constituting such Questionnaire,
which address will be supplied to the Company or the Selling Stockholders by you on request<B>; </B>provided further that notices under
subsection 5(f)&nbsp;shall be in writing, and if to the Underwriters shall be delivered or sent by mail, telex or facsimile transmission
to you at J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention: Equity Syndicate Desk and to Barclays 745
Seventh Avenue, New York, New York 10019, Attention: Syndicate Registration, Fax: 646-834-8133. Any such statements, requests, notices
or agreements shall take effect upon receipt thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement shall be binding upon, and inure solely to the benefit of, the Underwriters, the Company and the Selling Stockholders and, to
the extent provided in Sections 9 and 11 hereof, the officers and directors of the Company and each person who controls the Company, any
Selling Stockholder or any Underwriter, or any director, officer, employee or affiliate of any Underwriter, and their respective heirs,
executors, administrators, successors and assigns, and no other person shall acquire or have any right under or by virtue of this Agreement.
No purchaser of any of the Shares from any Underwriter shall be deemed a successor or assign by reason merely of such purchase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Time
shall be of the essence of this Agreement. As used herein, the term &quot;business day&quot; shall mean any day when the Commission's
office in Washington, D.C. is open for business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company and the Selling Stockholders, severally and not jointly, acknowledge and agree that (i)&nbsp;the purchase and sale of the Shares
pursuant to this Agreement is an arm's-length commercial transaction between the Selling Stockholders, on the one hand, and the several
Underwriters, on the other, (ii)&nbsp;in connection therewith and with the process leading to such transaction each Underwriter is acting
solely as a principal and not the agent or fiduciary of the Company or any Selling Stockholder, (iii)&nbsp;no Underwriter has assumed
an advisory or fiduciary responsibility in favor of the Company or any Selling Stockholder with respect to the offering contemplated hereby
or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company or any Selling
Stockholder on other matters) or any other obligation to the Company or any Selling Stockholder except the obligations expressly set forth
in this Agreement, (iv)&nbsp;the Company and each Selling Stockholder has consulted its own legal and financial advisors to the extent
it deemed appropriate and (v)&nbsp;none of the activities of the Underwriters in connection with the transactions contemplated herein
constitutes a recommendation, investment advice, or solicitation of any action by the Underwriters with respect to any entity or natural
person. Each of the Company and each Selling Stockholder agrees that it will not claim that the Underwriters have, or any of them has,
rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to the Company or any Selling Stockholder, in
connection with such transaction or the process leading thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company, the Selling Stockholders and
the Underwriters, or any of them, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement and any transaction contemplated by this Agreement and any claim, controversy or dispute arising under or related thereto shall
be governed by and construed in accordance with the laws of the State of New York without regard to principles of conflict of laws that
would results in the application of any other law than the laws of the State of New York. The Company and each Selling Stockholder agree
that any suit or proceeding arising in respect of this Agreement or any transaction contemplated by this Agreement will be tried exclusively
in the U.S. District Court for the Southern District of New York or, if that court does not have subject matter jurisdiction, in any state
court located in The City and County of New York and the Company and each Selling Stockholder agree to submit to the jurisdiction of,
and to venue in, such courts.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company, each Selling Stockholder and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable
law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated
hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Agreement may be executed by any one or more of the parties hereto in any number of counterparts, each of which shall be deemed to be
an original, but all such counterparts shall together constitute one and the same instrument. Counterparts may be delivered via facsimile,
electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act,
the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart
so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
anything herein to the contrary, the Company and the Selling Stockholders are authorized to disclose to any persons the U.S. federal and
state income tax treatment and tax structure of the potential transaction and all materials of any kind (including tax opinions and other
tax analyses) provided to the Company and the Selling Stockholders relating to that treatment and structure, without the Underwriters
imposing any limitation of any kind. However, any information relating to the tax treatment and tax structure shall remain confidential
(and the foregoing sentence shall not apply) to the extent necessary to enable any person to comply with securities laws. For this purpose,
 &quot;tax structure&quot; is limited to any facts that may be relevant to that treatment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">22.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Each
Selling Stockholder acknowledges and agrees that, although the Underwriters may provide the Selling Stockholders with certain Regulation
Best Interest and Form&nbsp;CRS disclosures or other related documentation in connection with the offering of the Shares, the Underwriters
are not making a recommendation to any Selling Stockholders to participate in the offering of the Shares or to sell any Shares at the
purchase price, and nothing set forth in the disclosures or documentation related to the offering of the Shares is intended to suggest
that the Underwriters are making such a recommendation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">23.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Recognition
of the U.S. Special Resolution Regimes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were
governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;As
used in this section:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;BHC Act Affiliate&rdquo;
has the meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Covered Entity&rdquo;
means any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;a &ldquo;covered
entity&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;a &ldquo;covered
bank&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii)&nbsp;a &ldquo;covered
FSI&rdquo; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Default Right&rdquo;
has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as
applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;U.S. Special Resolution
Regime&rdquo; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title
II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing is in accordance
with your understanding, please sign and return to us counterparts hereof, and upon the acceptance hereof by you, on behalf of each of
the Underwriters, this letter and such acceptance hereof shall constitute a binding agreement among each of the Underwriters, the Company
and each of the Selling Stockholders. It is understood that your acceptance of this letter on behalf of each of the Underwriters is pursuant
to the authority set forth in a form of Agreement among Underwriters, the form of which shall be submitted to the Company and the Selling
Stockholders for examination, upon request, but without warranty on your part as to the authority of the signers thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Pages&nbsp;Follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Very truly yours,</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">DoubleVerify Holdings,&nbsp;Inc.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Andy Grimmig</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name: Andy Grimmig</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title: Chief Legal Officer</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">Providence VII U.S. Holdings L.P.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">By: Providence Equity GP VII-A L.P.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Sarah Conde</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name: Sarah Conde</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title: General Counsel, Managing Director &amp; Chief Compliance Officer</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">Providence Butternut Co-Investment L.P.</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">By: Providence Equity GP VII-A L.P., its general partner</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">By: PEP VII-A International Ltd., its general partner</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> /s/ Sarah Conde</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:  Sarah Conde</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title: General Counsel, Managing Director &amp; Chief Compliance Officer</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted as of the date hereof<BR>
in New York, New York:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif">J.P. MORGAN SECURITIES LLC</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Ilana Foni</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name: Ilana Foni</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title: Executive Director</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BARCLAYS
    CAPITAL INC</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Douglas Melsheimer</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Douglas Melsheimer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Managing Director</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center">SCHEDULE I</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Optional</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares to be</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total
Number of</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Purchased if</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">Firm Shares</P></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Maximum Option</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Underwriter</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">to be Purchased</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercised</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: left">J.P. Morgan Securities LLC</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">6,250,000</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">937,500</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">Barclays Capital Inc.</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">6,250,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">937,500</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">Total</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">12,500,000</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,875,000</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">SCHEDULE II</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Optional</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Shares to be</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center"><B>Total Number of</B></TD><TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Sold if</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> Firm Shares</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Maximum Option</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">to be Sold</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercised</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">The Selling Stockholders:</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; width: 74%; text-align: left">Providence VII U.S. Holdings L.P.(a)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">12,419,952</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">1,862,992</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.25in; text-align: left">Providence Butternut Co-Investment L.P.(b)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">80,048</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,008</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">12,500,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,875,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Selling Stockholder is represented by Morgan J. Hayes, Debevoise&nbsp;&amp; Plimpton LLP, 919 Third Avenue, New York, New York 10022
and Richards, Layton&nbsp;&amp; Finger, P.A., One Rodney Square, 920 North King Street, Wilmington, DE 19801.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;This
Selling Stockholder is represented by Maples and Calder (Cayman) LLP, Attn: Tim Coak, PO Box 309 Ugland House, Grand Cayman KY1-1104,
Cayman Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Issuer
Free Writing Prospectuses not included in the Pricing Disclosure Package</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">None</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Additional
documents incorporated by reference</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">None</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Information
other than the Pricing Prospectus that comprise the Pricing Disclosure Package</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 1in">The launch press release
filed with the Commission as a Free-Writing Prospectus on March&nbsp;6, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 1in">The public offering
price per share for the Shares is the price to be paid by each investor in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 1in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">The aggregate number of Shares purchased
by the Underwriters is 12,500,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>ANNEX I(a)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF OPINION OF<BR>
COUNSEL FOR THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>ANNEX I(b)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF OPINION OF<BR>
COUNSEL FOR THE SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right"><B>ANNEX II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF LOCK-UP AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DoubleVerify Holdings,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Lock-Up Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[&#9679;], 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">J.P. Morgan Securities LLC</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Barclays Capital Inc.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">c/o</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%">J.P. Morgan Securities LLC</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">383 Madison Avenue</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">New York, New York 10179</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">c/o</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Barclays Capital Inc.</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">745 Seventh Avenue</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">New York, New York 10019</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: 0.4in; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Re: <U>DoubleVerify
Holdings,&nbsp;Inc. - Lock-Up Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that J.P. Morgan Securities LLC and Barclays Capital Inc., as underwriters (the &ldquo;<U>Underwriters</U>&rdquo;), propose to enter into
an underwriting agreement (the &ldquo;<U>Underwriting Agreement</U>&rdquo;), with DoubleVerify Holdings,&nbsp;Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;) and the stockholders of the Company named in Schedule II to the Underwriting Agreement, providing for
a public offering (the &ldquo;<U>Offering</U>&rdquo;) of shares of common stock, par value $0.001 per share, of the Company (&ldquo;<U>Common
Stock</U>,&rdquo; and such shares, the &ldquo;<U>Shares</U>&rdquo;) pursuant to a Registration Statement on Form&nbsp;S-3 (File No.&nbsp;333-267676)
filed with the Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of the agreement
by the Underwriters to offer and sell the Shares, and of other good and valuable consideration the receipt and sufficiency of which is
hereby acknowledged, the undersigned agrees that, during the period beginning from the date of this lock-up agreement (this &ldquo;<U>Lock-Up
Agreement</U>&rdquo;) and continuing to and including the date 45 days after the date (the &ldquo;<U>Offering Date</U>&rdquo;) set forth
on the final prospectus (the &ldquo;<U>Prospectus</U>&rdquo;) used to sell the Shares (the &ldquo;<U>Lock-Up Period</U>&rdquo;), the undersigned
shall not, and shall not cause or direct any of its affiliates to, (i)&nbsp;offer, sell, contract to sell, pledge, grant any option to
purchase, lend or otherwise dispose of any shares of Common Stock of the Company, or any options or warrants to purchase any shares of
Common Stock of the Company, or any securities convertible into, exchangeable for or that represent the right to receive shares of Common
Stock of the Company (such options, warrants or other securities, collectively, &ldquo;<U>Derivative Instruments</U>&rdquo;), including
without limitation any such shares or Derivative Instruments now owned or hereafter acquired by the undersigned, (ii)&nbsp;engage in any
hedging or other transaction or arrangement (including, without limitation, any short sale or the purchase or sale of, or entry into,
any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or
defined) which is designed to or which reasonably could be expected to lead to or result in a sale, loan, pledge or other disposition
(whether by the undersigned or someone other than the undersigned), or transfer of any of the economic consequences of ownership, in whole
or in part, directly or indirectly, of any shares of Common Stock of the Company or Derivative Instruments, whether any such transaction
or arrangement (or instrument provided for thereunder) would be settled by delivery of Common Stock or other securities, in cash or otherwise
(any such sale, loan, pledge or other disposition, or transfer of economic consequences, a &ldquo;<U>Transfer</U>&rdquo;) or (iii)&nbsp;otherwise
publicly announce any intention to engage in or cause any action or activity described in clause (i)&nbsp;above or transaction or arrangement
described in clause (ii)&nbsp;above. The undersigned represents and warrants that the undersigned is not, and has not caused or directed
any of its affiliates to be or become, currently a party to any agreement or arrangement that provides for, is designed to or which reasonably
could be expected to lead to or result in any Transfer during the Lock-Up Period. For the avoidance of doubt, if the undersigned is an
officer (as defined under the rules&nbsp;and regulations of the Financial Industry Regulatory Authority,&nbsp;Inc. (&ldquo;<U>FINRA</U>&rdquo;))
or director of the Company, the undersigned further agrees that the foregoing provisions shall be equally applicable to any issuer-directed
or other Shares the undersigned may purchase in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the undersigned is not
a natural person, the undersigned represents and warrants that no single natural person, entity or &ldquo;group&rdquo; (within the meaning
of Section&nbsp;13(d)(3)&nbsp;of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;)), other than
a natural person, entity or &ldquo;group&rdquo; (as described above) that has executed a lock-up agreement in substantially the same form
as this Lock-Up Agreement, beneficially owns, directly or indirectly, 50% or more of the common equity interests, or 50% or more of the
voting power, in the undersigned.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
the undersigned may:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;transfer the undersigned&rsquo;s
shares of Common Stock of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;as
a <I>bona fide</I> gift or gifts or for <I>bona fide </I>estate planning purposes; <I>provided </I>that each donee agrees to be bound
in writing by the restrictions set forth herein; and&nbsp;<I>provided further&nbsp;</I>that, to the extent a filing under Section&nbsp;16(a)&nbsp;of
the Exchange Act reporting such transfer of the undersigned&rsquo;s shares of Common Stock shall be required, the undersigned shall disclose
therein that such transfer is a transfer as a bona fide gift or gifts or is for bona fide estate planning purposes and is not a disposition
for value and otherwise no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act shall be voluntarily made during the&nbsp;Lock-Up&nbsp;Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
any person related to the undersigned by blood, marriage, domestic partnership or adoption, not more remote than first cousin (any such
person, an &ldquo;immediate family member&rdquo;) or to any trust for the direct or indirect benefit of the undersigned or an immediate
family member of the undersigned, or if the undersigned is a trust, to a trustor or beneficiary of the trust (including such beneficiary&rsquo;s
estate) of the undersigned; <I>provided</I> that the transferee agrees to be bound in writing by the restrictions set forth herein; <I>provided
further</I> that any such transfer shall not involve a disposition for value; and <I>provided further </I>that no filing under Section&nbsp;16(a)&nbsp;of
the Exchange Act reporting such transfer of the undersigned&rsquo;s shares of Common Stock shall be required or shall be voluntarily made
during the&nbsp;Lock-Up&nbsp;Period (other than any required Form&nbsp;5 filing after the end of the calendar year in which such transaction
occurs);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;upon
death or by will, testamentary document or intestate succession; <I>provided</I> that the transferee agrees to be bound in writing by
the restrictions set forth herein; <I>provided further</I> that any such transfer shall not involve a disposition for value; and <I>provided
further </I>that no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act reporting such transfer of the undersigned&rsquo;s shares
of Common Stock shall be required or shall be voluntarily made during the&nbsp;Lock-Up&nbsp;Period (other than any required Form&nbsp;5
filing after the end of the calendar year in which such transaction occurs);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
connection with a sale of the undersigned&rsquo;s shares of Common Stock acquired (A)&nbsp;from the Underwriters in the Offering or (B)&nbsp;in
open market transactions after the Offering Date; <I>provided</I> that this paragraph (4)&nbsp;shall not apply if the undersigned is an
officer (as defined under the rules&nbsp;and regulations of FINRA) or director of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(5)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
connection with the sale or transfer of the undersigned&rsquo;s shares of Common Stock in connection with the exercise of options, including
 &ldquo;net&rdquo; or &ldquo;cashless&rdquo; exercises, or the vesting or settlement of restricted stock units or other rights to purchase
shares of Common Stock, for the payment of tax withholdings or remittance payments due as a result of the exercise of any such options
or vesting or settlement of such restricted stock units or other rights to purchase shares of Common Stock, in all such cases, pursuant
to equity awards granted under an equity incentive plan described in the Prospectus; <I>provided</I> that any filing under Section&nbsp;16(a)&nbsp;of
the Exchange Act, or any other public filing or disclosure of such transfer by or on behalf of the undersigned, shall clearly indicate
in the footnotes thereto the nature and conditions of such transfer; and <I>provided further</I> that any shares of Common Stock received
upon the exercise or settlement of the option, restricted stock units or other equity awards shall be subject to this Lock-Up Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(6)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
connection with the disposition of shares of Common Stock to the Company, or the withholding of shares of Common Stock by the Company,
in connection with the exercise of options, including &ldquo;net&rdquo; or &ldquo;cashless&rdquo; exercises, or the vesting or settlement
of restricted stock units or other rights to purchase shares of Common Stock, for the payment of tax withholdings or remittance payments
due as a result of the exercise of any such options or vesting or settlement of such restricted stock units or other rights to purchase
shares of Common Stock, in all such cases, pursuant to equity awards granted under an equity incentive plan described in the Prospectus;
<I>provided</I> that any filing under Section&nbsp;16(a)&nbsp;of the Exchange Act or any other public filing or disclosure of such transfer
by or on behalf of the undersigned, shall clearly indicate in the footnotes thereto the nature and conditions of such transfer; and <I>provided
further</I> that any shares of Common Stock received upon the exercise or settlement of the option, restricted stock units or other equity
awards shall be subject to this Lock-Up Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(7)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
the undersigned is a corporation, partnership, limited liability company, trust or other business entity, (A)&nbsp;to another corporation,
partnership, limited liability company, trust or other business entity that is an affiliate (within the meaning set forth in Rule&nbsp;405
as promulgated by the SEC under the Securities Act of 1933, as amended) of the undersigned, (B)&nbsp;to any investment fund or other entity
controlling, controlled by, managing or managed by or under common control with the undersigned or affiliates of the undersigned (including,
for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or any
other funds managed by such partnership) or (C)&nbsp;as part of a distribution, transfer or disposition by the undersigned to its stockholders,
limited partners, general partners, limited liability company members or other equityholders or to the estate of any such stockholders,
limited partners, general partners, limited liability company members or equityholders; <I>provided </I>that it shall be a condition to
such transfer that the transferee or distributee agrees to be bound in writing by the restrictions set forth herein; <I>provided further
</I>that no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act reporting such transfer of the undersigned&rsquo;s shares of Common
Stock shall be required or shall be voluntarily made during the&nbsp;Lock-Up&nbsp;Period (other than any required Form&nbsp;5 filing after
the end of the calendar year in which such transaction occurs);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(8)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;by
operation of law, such as pursuant to a qualified domestic relations order or in connection with a divorce settlement; <I>provided</I>
that the transferee agrees to be bound in writing by the restrictions set forth herein; <I>provided further</I> that any filings under
Section&nbsp;16(a)&nbsp;of the Exchange Act, or any other public filing or disclosure of such transfer by or on behalf of the undersigned,
shall clearly indicate in the footnotes thereto that such transfer was by operation of law pursuant to a qualified domestic relations
order or in connection with a divorce settlement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(9)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
the Company, in connection with the repurchase of shares of Common Stock issued pursuant to equity awards granted under an equity incentive
plan, which plan is described in the Prospectus, or pursuant to the agreements pursuant to which such shares were issued, as described
in the Prospectus, in each case, upon termination of the undersigned&rsquo;s relationship with the Company; <I>provided </I>that any filings
under Section&nbsp;16(a)&nbsp;of the Exchange Act, or any other public filing or disclosure of such transfer by or on behalf of the undersigned,
shall clearly indicate in the footnotes thereto that such transfer was to the Company in connection with the repurchase of shares of Common
Stock;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(10)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;pursuant
to a bona fide third-party tender offer, merger, consolidation or other similar transaction made to all holders of the Company&rsquo;s
Common Stock and approved by the board of directors of the Company, and the result of which is that any &ldquo;person&rdquo; (as defined
in Section&nbsp;13(d)(3)&nbsp;of the Exchange Act), or group of persons, becomes the beneficial owner (as defined in Rules&nbsp;13d-3&nbsp;and&nbsp;13d-5&nbsp;of
the Exchange Act) of at least 50% of total voting power of the voting stock of the Company or the surviving entity (a &ldquo;Change of
Control Transaction&rdquo;); <I>provided </I>that in the event that the Change of Control Transaction is not completed, the undersigned&rsquo;s
shares shall remain subject to the provisions of this&nbsp;Lock-Up&nbsp;Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(11)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;pursuant
to a written plan meeting the requirements of Rule&nbsp;10b5-1 under the Exchange Act (a &ldquo;<U>10b5-1 Plan</U>&rdquo;) in existence
as of the date of the Prospectus, <I>provided</I> that any filing under Section&nbsp;16(a)&nbsp;of the Exchange Act, or any other public
filing or disclosure of such transfer by or on behalf of the undersigned, shall clearly indicate in the footnotes thereto the nature and
conditions of such transfer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(12)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;pursuant
to a 10b5-1 Plan entered into after the date of the Prospectus; provided that (A)&nbsp;no sales may be made pursuant to this clause (12)
if the undersigned sells shares of Common Stock in the Offering; (B)&nbsp;sales pursuant to this clause (12) must be made in accordance
with the DoubleVerify Holdings,&nbsp;Inc. Policy on Trading in Securities as in effect on the date hereof; and (C)&nbsp;the undersigned
may sell shares of Common Stock pursuant to this clause (12) up to an amount not to exceed 20% of the sum of (x)&nbsp;the undersigned&rsquo;s
shares of Common Stock and (y)&nbsp;the undersigned&rsquo;s securities convertible into or exercisable or exchangeable for Common Stock
(on an as-converted, as-exercised or as-exchanged basis), calculated as of the date of this Lock-Up Agreement; provided further that any
filing under Section&nbsp;16(a)&nbsp;of the Exchange Act, or any other public filing or disclosure of such transfer by or on behalf of
the undersigned, shall clearly indicate in the footnotes thereto the nature and conditions of such transfer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(13)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[in
connection with the pledge, hypothecation or other granting of a security interest in shares of Common Stock or securities convertible
into or exchangeable for shares of Common Stock to one or more lending institutions as collateral or security for any loan, advance or
extension of credit, <I>provided</I> that the undersigned shall provide the Underwriters with prior written notice informing them of any
public filing, report or announcement with respect to such pledge, hypothecation or other grant of a security interest; and <I>provided
further</I> that no transfer upon foreclosure upon such shares of Common Stock or such securities to such lending institution shall be
made during the Lock-Up Period;]<FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(14)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[<I>provided</I>
that the aggregate proceeds received by the undersigned in connection with any such transfers during the Lock-Up Period (excluding any
amounts received pursuant to the exceptions included above) does not exceed $200,000]<FONT STYLE="font-size: 10pt"><SUP>2</SUP></FONT>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(15)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;with
the prior written consent of the Underwriters; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in">(16)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
the undersigned is a corporation, in connection with the corporation&rsquo;s transfer of the capital stock of the Company to any wholly-owned
subsidiary of such corporation; <I>provided</I> that it shall be a condition to the transfer that the transferee execute an agreement
stating that the transferee is receiving and holding such capital stock subject to the provisions of this Lock-Up Agreement and there
shall be no further transfer of such capital stock except in accordance with this Lock-Up Agreement; and <I>provided further</I> that
any such transfer shall not involve a disposition for value; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;enter into a 10b5-1
Plan relating to the transfer, sale or other disposition of securities of the undersigned, if then permitted by the Company, <I>provided</I>
that the securities subject to the plan may not be sold during the Lock-Up Period (except to the extent otherwise allowed pursuant to
clause (a)&nbsp;above).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned now has, and
except as contemplated by clause (a)&nbsp;above, for the duration of this Lock-Up Agreement will have, good and marketable title to the
undersigned&rsquo;s shares of Common Stock of the Company, free and clear of all liens, encumbrances and claims whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees and
consents to the entry of stop transfer instructions with the Company&rsquo;s transfer agent and registrar against the transfer of the
undersigned&rsquo;s shares of Common Stock of the Company except in compliance with the foregoing restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned acknowledges
and agrees that none of the Underwriters has made any recommendation or provided any investment or other advice to the undersigned with
respect to this Lock-Up Agreement or the subject matter hereof, and the undersigned has consulted its own legal, accounting, financial,
regulatory, tax and other advisors with respect to this Lock-Up Agreement and the subject matter hereof to the extent the undersigned
has deemed appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned understands
that the Company and the Underwriters are relying upon this Lock-Up Agreement in proceeding toward consummation of the Offering. The undersigned
further understands that this Lock-Up Agreement is irrevocable and shall be binding upon the undersigned&rsquo;s heirs, legal representatives,
successors, and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><SUP>1
</SUP></I></FONT><I>To be included only in the lock-up agreement of Providence VII U.S. Holdings L.P.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><SUP>2
</SUP></I></FONT><I>To be included for DV&rsquo;s CEO and CFO.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything
to the contrary contained herein, this Lock-Up Agreement will automatically terminate and the undersigned will be released from all obligations
hereunder upon the earliest to occur, if any, of: (i)&nbsp;the Company notifies the Underwriters, in writing, prior to the execution
of the Underwriting Agreement, that it has determined not to proceed with the Offering, (ii)&nbsp;the Company files an application with
the SEC to withdraw the registration statement related to the Offering, (iii)&nbsp;the Underwriting Agreement is executed but is then
terminated (other than the provisions thereof which survive termination) prior to payment for and delivery of the Shares to be sold thereunder,
or (iv)&nbsp;the Underwriting Agreement does not become effective by March&nbsp;31, 2023 (provided, that the Company may, by written
notice to the undersigned prior to such date, extend such date for a period of up to an additional 90 days).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned hereby consents
to receipt of this Lock-Up Agreement in electronic form and understands and agrees that this Lock-Up Agreement may be signed electronically.
In the event that any signature is delivered by facsimile transmission, electronic mail, or otherwise by electronic transmission evidencing
an intent to sign this Lock-Up Agreement, such facsimile transmission, electronic mail or other electronic transmission shall create a
valid and binding obligation of the undersigned with the same force and effect as if such signature were an original. Execution and delivery
of this Lock-Up Agreement by facsimile transmission, electronic mail or other electronic transmission is legal, valid and binding for
all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Lock-Up Agreement and
any claim, controversy or dispute arising under or related to this Lock-Up Agreement shall be governed by and construed in accordance
with the laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>[Remainder of Page&nbsp;Intentionally
Left Blank]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: -3.15in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.5pt 1pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>IF AN INDIVIDUAL:<FONT STYLE="font-size: 10pt"><SUP>3</SUP></FONT></B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P></TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 1.5pt 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>IF AN ENTITY:</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 1.5pt 1pt; vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: top; width: 44%">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom; width: 5%">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom; width: 44%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1.5pt 1pt; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(duly authorized signature)</I></FONT></TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; border-top: black 1pt solid; padding: 1.5pt 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(please print complete name of entity)</I></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 1.5pt 1pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 1pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1.5pt 1pt; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(please print full name)</I></FONT></TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1.5pt 1pt; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(duly authorized signature)</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P></TD></TR>
  <TR>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 1pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1.5pt 1pt; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(please print full name)</I></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 1pt; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title: </FONT></TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="padding: 0.75pt 1pt; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; padding: 1.5pt 1pt; vertical-align: top; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(please print full title)</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I><SUP>3
</SUP></I></FONT><I>NTD: Lock-ups to be signed by CEO, CFO and Providence-designated directors (and Providence selling stockholders).</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>dv-20230306.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa6CKbOdzZR+WYkxtmBzbZnqLy8r36Om/iqdBhEWQbMF -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dv="http://doubleverify.com/20230306" elementFormDefault="qualified" targetNamespace="http://doubleverify.com/20230306">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://doubleverify.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="dv-20230306_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="dv-20230306_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>dv-20230306_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>dv-20230306_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.17a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://doubleverify.com/role/Cover" xlink:href="dv-20230306.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://doubleverify.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140032354991504">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 06, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  06,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DoubleVerify Holdings, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001819928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-2714562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">462 Broadway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-2111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm237751d3_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="dv-20230306.xsd" xlink:type="simple"/>
    <context id="From2023-03-06to2023-03-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001819928</identifier>
        </entity>
        <period>
            <startDate>2023-03-06</startDate>
            <endDate>2023-03-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-03-06to2023-03-06">0001819928</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-03-06to2023-03-06">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-03-06to2023-03-06">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-03-06to2023-03-06">2023-03-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-03-06to2023-03-06">DoubleVerify Holdings, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-03-06to2023-03-06">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-03-06to2023-03-06">001-40349</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-03-06to2023-03-06">82-2714562</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-03-06to2023-03-06">462 Broadway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2023-03-06to2023-03-06">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-03-06to2023-03-06">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-03-06to2023-03-06">10013</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-03-06to2023-03-06">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-03-06to2023-03-06">631-2111</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-03-06to2023-03-06">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-03-06to2023-03-06">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-03-06to2023-03-06">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-03-06to2023-03-06">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-03-06to2023-03-06">Common stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-03-06to2023-03-06">DV</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-03-06to2023-03-06">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-03-06to2023-03-06">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,N)9U8'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #+B6=6HA@8NN\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9)1
M2\,P$,>_BN2]O285E=#U9<,G!<&!XEM(;EM8DX;DI-VW-ZU;A^@'$/*2NW]^
M]SM(HX/4?<27V >,9#'=C*[S2>JP8@>B( &2/J!3J<P)GYN[/CI%^1KW$)0^
MJCV"J*H[<$C**%(P 8NP$%G;&"UU1$5]/..-7O#A,W8SS&C #AUZ2L!+#JR=
M)H;3V#5P!4PPPNC2=P'-0IRK?V+G#K!S<DQV20W#4 [UG,L[<'A_?GJ=URVL
M3Z2\QOPJ64FG@"MVF?Q6KS?;1]:*2M1%E<_]5@C);R5_^)A<?_A=A5UO[,[^
M8^.+8-O KW_1?@%02P,$%     @ RXEG5IE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M]P(\CY6R[PUW7*W^VS#Y%U!+ P04    " #+B6=6GZ ;\+$"  #B#   #0
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M?P%02P$"% ,4    " #+B6=6!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,N)9U:B&!BZ[P   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( ,N)9U:97)PC$ 8  )PG   3              "  <T!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ RXEG5HC8E*E'!   >1   !@
M         ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( ,N)9U:?H!OPL0(  .(,   -              "  8L,  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ RXEG5I>*NQS     $P(   L
M ( !9P\  %]R96QS+RYR96QS4$L! A0#%     @ RXEG5JK$(A8S 0  (@(
M  \              ( !4!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M ,N)9U8D'INBK0   /@!   :              "  ; 1  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( ,N)9U9ED'F2&0$  ,\#   3
M              "  942  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  -\3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm237751d3_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://doubleverify.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm237751d3_8k.htm">tm237751d3_8k.htm</File>
    <File>dv-20230306.xsd</File>
    <File>dv-20230306_lab.xml</File>
    <File>dv-20230306_pre.xml</File>
    <File>tm237751d3_ex1-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm237751d3_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm237751d3_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dv-20230306_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dv-20230306_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dv-20230306.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "dv",
   "nsuri": "http://doubleverify.com/20230306",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm237751d3_8k.htm",
      "contextRef": "From2023-03-06to2023-03-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://doubleverify.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm237751d3_8k.htm",
      "contextRef": "From2023-03-06to2023-03-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://doubleverify.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001104659-23-029645-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-029645-xbrl.zip
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M&_"&YBC^BS@TD<VM4;=33;W\"U!+ P04    " #+B6=6]_V"=_\*  !LAP
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M]I$Q$/AK3. >A8C,'Q01FCE&$.C'UD#J;U!O2#P:$;&/YY1SE^P1 >KM5?9
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M6O7+BQ?YR,;%QT_L]&!AZ=K0_RA522%%RF5W7Z3]:OZP0/OSQK%VV3Q'^\X
M6SR\L<QI5Y)Y0IA,'MF:Q^9WEHP_:-/<=9;%_KYNT>ONXT]K>"(#NK^:4(3I
M)4J%Y-EB-K&?9IR6/E?7L1D.F&^S>M%&S>K59;/]N4*\%6&T$%<>=3QLN<BU
MH9?&EMA(SB";(CFWI?] =F=?I3P9<WN$07C4< T@6AUK/6Q!["IK+D A>3>3
M_=.$9VD0X[U)!C9UT5;PG6"8XHCC(E@>@FHH;R;ZCR(ZQU3KH9UMQ,P=;2VZ
M667!S:YX2E45"5>TOYGJJ/%T6R-WE]J[_4U41PX2QM@MZD"I#_UZ.IY,0!!B
M1?GC'&.)DA K+\1:X:(__L!8N#@^!7]\Q.JJ2;J&P\I++EMM1@]/QB"G->NJ
M,#F/(1I&D04KY(6(6UZ(0">VR6J<(&C=TE*?$2VCE;=5'6-P;,8[\P@ZY1EA
M!SD#HK&EC8X,T*[K( @%X"#T TW$Q: CX,XT00,:KP)+"?Y]@'4]^/YFHJ$\
M<)K>:;9IXH$#25SPFU@8[+LT(# DU#4T; 9:$QEAL'[8=_4 <%FU4YH9A:6>
MW$!#;"<[N&^8D^)KC(=338GEFA'67IVS=K GFT(@XV74E@M^7Q$%PXJMKS!^
M,IK8SQVGNC.*(S2Q8B];L;ID0.TALZSYV+0&F^ LQ,0CB&HO>H;_JZLO#XBO
M?*;[P,*BP+YTW&ISXU8S3 )2JH1&#]+Q[UY!424ZUN)(V!9ILM*&G,Q*&98/
M_WU5GIU3>1N/ZW[Y1N-V^)+^;W;:QQ>WCU>[K=W8]+^" <B@E:2R(V=S>67-
MT8 ?]+7H!8O=M4)7G&.PQ5V;Y9DV))84/4)>Z>B&2$!AP@FR3B,<#GZ\:&=1
M#+_-X&(5L&+W^X;#]B\1<R<DAO"/$J'>;*%J?V#:$QBA>8-$%W;J1[2AI?E<
M7?HG"U@GM&5W/SJTS>>\95VGQ''\CX9A$3DZK#WWZK^[M]?WVC"VJ!9!.U'*
MYA5T2&VLC_!DC9BF1BAK7@$B;BQJ08G20@5^O:1M>V1%Z^!T?%YN[_9V55F)
M6PDSTHD2&]Y[FSZM$'][J9HC10G# ^HEO8+<"H+FBHQN=-SXF=>[Y/SN_1*]
M.:6+9O!5N>=&_V,2BX_WOGS44%W9H#/SES%8G7H;NXWA5?:D41]UXC:].>J)
M$D0]>=6:_SW9Q!NB8*R3E2\=2QX&% S,&& 3D3'1/-<8LD4L3%W$B9Y_OW*2
MA8% ;"0^?S;]F,H!.,%272PH/[.H5Z8$K[9[[]RH5^[N,H\G<63387J)DB*O
MRII_+(7879_CA@VF?=6SK1?78'J^IJOJ-2GGU1BX7J29*.4S<E*19?D+ZT&S
MJM5__E50Y)T]!^!,,F!L(HOSN8W [4R/Y6&;&[!&QR [M^L_JRH,!GR1+G^&
M3FLPDT)F+8ILE$^L\!6+0 ;:["!18X=0Q&;,S0T3.T$Y^GNI-2S>H^? .F&R
M1*72(]H38ML(> #I @1IM@)4[3%2B6F/F+BLD2E%,%1(GJ&.88(Y(<,!VW*)
MI1-]<\.U01]]SW2Q16S/,2?(@36)TYGP_GX/6P5N<+"<9 VA&J8'B$#1UB1H
MZT".;X]8/Y;(&&S5YA2_E887$,:8M*S$]!/TP8O1B:6T)@B//ZGAPK"PM:YG
M^4M#)SI&%M3,[:UQ/SH[)K%L=*BV;1)L\3-*X>@9R9(8@<+>:ZDF_]C<\'$
M7V$D:!#:+&.;]V)4LTK.-ZB%+3*V,[8E[Z!*K8E "RD _%Y>N[9-O6 )A[XE
MM&S3T$!NJWL.;@V^;:XP@YWVY/S\O.5Z\>QWK3*#97[6M('8'(N=?>$H9ZR
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MNU*CL7/G/<:@_SF"B=+1[=]*K?D%RP[\??6)O^R)U;D^/QS=]]^_\[*X14:
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MJO*W"&D'_UO^>3_*BQK$L)QE--<$+VT0T&@%OZO@XL^*4F_[":IB5DVG8 F
MY'8OK\@YG 4P&NJ#=#IES;6[0XM%I@ :)2D>B5$ZAM]&[D.X6C!%T-E\$>1@
M$X ;$U'$#=X*:Y/C]<FWGGXK3RNZ!@9&!4_@,8%]1/</J5BWK%D.BTAV2U'&
M.N-/>7$#JWV9ZF;((8]ID>#3*#IRT_B5C77@L+39F+Y;D-ED[F?_:1@+OVQ9
MI9M.(5C6J+6J]FX)9/IH[W)_[WB??_3BC3(-"[&[0RM1IN,4'FLG1HJ-I&A$
M5U=9D(@N*Y%&6$1<UC7#C]DD3,$!AFL4_GUSE<&',WIY-(=)T;O!?UC)4!JR
M;D0:_U_9(9ZTO'"_.^LR]K=],@75&K5O_%=)!0KCO9N4G%R4/Q@(:',TK?.D
M7-F)[V7Y>+8D2:0MZ?Y4M5PLR!NJ]V%NLX2BIC)>.=C]<PPL!+.-QT_W1IU[
MV#W3)'(.B!]CQVSQ*=<)K.B2=[/[0(EYK_OIU@#,]I2S1I430SP&S67J6)J^
ME2%+*AM8(5 H\(8);C1)ZW56UDN2 ;-:)X>OQ"[<2$3I1C9Z78RY&NY"_J(^
M!7_;LS MI18;4T[VIL^>XZWZ8$?WL7%O\58UI=;>1KPP?H71&YO#(J&"FZW"
M8W,&'\K&"?@G=.%'>^96S,CY\I;I$5A.>UF6B?2Q#MT?.&+^1GQ?9F/<XA[!
M(Y4@JPKO!G/:B,J7G)QHX."P&T(G!SS!,3A>DP2=8WID,/%G:#*:.:]7*MWJ
M!*8RA:_A2\2PYRGM[K2W$Q_67K68'M-]E%$E\K?\*;O"DPG"+Z<$7D=#B(+C
MF;("+<9+E!:X".#7XH7RR?+#KF7<=HG/03S!2\3]"PV=0#V1@,H6JZ[F$^6&
MVU@CNAKQ-_Z&*TJK.$0>.H["5U@C/%1#=R^/I?ODQMMKOP&MMZ%XNWM!S3&W
MP?+P3@-7+4ACZ3YM6;HJY=[<#"Q>6;5A$2)S@-3M&(T*/DCA1=ZUM20RW7L;
M[^ZT=I>&CK^BE\R3%6QT\RBVI&QP+[>3ER3/EZ#-P"LL_+VA)A5O@]W.4-V>
M.+4#\SIZMC?1G_@QP5;Y]?/2B2L):S(=FHW>LOW[)59;]_=/G72)2("0+F$@
M4W0B-$^\:"I#6)O@EK'W=4-M])V/'F,GUW&<\SC>XCC^*N-H*>7]N\S/WGG"
MMPO+@,B!4_C\WY>X-_!8AA$0L*B%;.#,T=%Q1^KH.X-CT-^UH P=*!R+W7@O
M^(;VZT?@'7TZ&*5PK<,8%S1F.Z3O.D:$P]SVE198<;\Q%;>,F-QQR&3O3#3(
M+P7J2CQFX+E@^@N/1]%RL,4G';Y.\:_#I\VXV?BY+I^9359PFD%7C-.41C E
M;0[J"30DYA_(Y>M3EB_.5+N2-KQ,LKRJ VT+WR9=PBH;_U* IBQIYC;6LKOS
M]:(">Z]D ^CBZ[G&Q.D \P<-<G@)!T0B"5K$F&U!@YEU)UY&<WAKF=$]0P^I
M=*PE*(JL3/G6M^LCT>L2%&_%(\)?@4.SG)&&KSHC%3@ TLX\FTDVH?@1C*=.
M<"@YZ.ZZ!!_,Q"Q ?/SXILF8C+ABGM$6TN=:'Y!13S2@SPFE6H/V\/T\':=5
MA>L&'YDGG]B"=6^M B,#_S1#Q(_.:9R58 G!IT&%5G+=<# "_KJ*;N"K\- )
M^&TX.YC^+$TF%)):< IM$D=7Q0T<G)+23+1?6>5COWQ)FOCO2JP&?%X"IM]*
MC0XS9%X66NJ*7L_1P%E&3LER(4^D; #M?P:/)0.1 A4F?AR=T]\EAS3@T+W<
M&UN3P@9.]O5H=Z10!I[?R&4<@4FZ=^T\QO9;[O$%?%N5?5<Z&WPI]E!%_55=
MT2T?VFTX\I),@T^__!ZS9D_F$F[>^RFI,,5,,8U]C*3U1\].K1>ZN],PJX,
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MA9OOK0Z': ]9_)5#UQLKH]3:*__*;&_;%=]_!<O/!EO,L1,C(:9XVH*5/L'
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MCAUU^8$6I$^W5I:4<C(FR\SIX"[E2Y4]7B$&(Q=OR)5L2X&#JP[#Q9?E"/9
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M;[3T':71[T;A15^H[_@8?+'">P+^R:JAN(8N73<[20!A^+5092G;N<'9"\S
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MS(:[9ONR:G==7AI-3H3>7"-WY<FENW(4'6O?4W/06('(,"%ZQ"MW*.?Z"^\
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M,I1)5M/;"N6V@H,#-XF'M@RA/4Z-:KYLQ3>5*A81=8$[W1?;^]JG)2NQ!?A
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M,YQP[AJ#_%DY'QWZ&<X(PB$+F7I2H7M4N1+90O''E6-&3<:<?,5KC:L?5I+
M98N6J^*OL[)>IJX"VO-([.[\XF.3I8,"!9$N5V;9624M1>*)'SLM#XW<5 S/
M87MGOAY37_E #N^SNSJ\A-AQ:ZN$!%5%T9;V]FDK!1>%5JR]8&A'RRK+\;Z=
M)"L!T9H&"%QQC'51 G%Z[4JA_T3A591[/*U_32K,RM:H.-X\>?W_M_>M/6TD
MVZ+?+?D_M'+.S 6I<; )24BRD7AF?#<!!&3V'8WVA[+=F#ZQN[W[ ?'Y]7<]
MJJJK7\8&-]B.-5(&V]WU6+5JO1\-3&8!I9(+G*HY5N0HW\_3RSH-K9S8G$IT
M=?&11&MEL295QC05OI#//*=4@I):,JK 83#\/^'6P(%CON.:R$$7"[20R")+
M+1BU)LN<@>GR*TD NMQCMN"'68G%-BH0IFM"$*>7%9+3Y90HWU_VQ-$RKKGD
M7#X=[K;+924DYZ/*&Z/ ];"$\T"? 4?D2+_RK=N+ 1R)%^#Q7"K;K+N:J3%!
M.3M4E+B'T>K !^Y!O@O&Z:F0=V %$ND(0"^TN/>#Z9>0BY.1S)4+&R"O1)9&
M_CT.R]?E<G*@96T8MA08'(U*<'+IH,)Z$K0M%HT![.25H>K%]'W6L);>1LJN
MAF@BB[H(5 W#3>UUIF_3R5)3PD:5=L_$!R7]7 PE/!=K8&<JT4[5O0=!@HJ2
MK% F:Q]S$15\\=;UA$>73N*##A5@"0K6$6E^:Q1TH^*=]QK3/'WY$='O694H
M"GLJJ;!F7)\PCR18S4%K>PX7K>$2ZCW=)@DC(#C8 ?;1=4BF0A]+UY5U(:2<
MH<A*@9\NWPAHK$K_8+56$<5$35@6:E@GAFMTJK-0B3"J6I(K0^&XS*QN3)!:
M$PI81KP#!97@H=H83H,/XKFHFPSBU#VIG2JR2W#M?RT2TDC^ X'0("^!*O1N
M]>)H/#T^<T>P['GFZ.'D^[W /'Q*5^'[M:OPE5V%[]>NPD6Y,[/(O1^JLC_$
M2*,=*F<]H#)8:2,/4FG9'XW+=H5)76Y5%(MT2C'83 F@1=&$.2-$WB66)>#Y
M8&(25[G!IY0W%C^08I;Z.H?[S8\5'3:7 !VG.$Y*@B!6G](^U"NR\30;<(#8
MA6,.)0Q'7%B)!49MU."2D3TMF"8^I#Z^[:F&>3TV30<QVYV*G-@#\:#E(W*F
MX =M]U1AVQSIR0Y54A4&C@J3O07)AB*X:23.E^;RBRK$4^;XRMJ&I@C$ BQZ
MOBFW^-'UI"I%3B'BX 60KH@P=F4]2MT:08$U7:$['U8[XYDJZWX4N)SS,(A#
M"KK5_62_-ZX;UC%5N(,YC_PX,,(T =P %"_YW3P/M,A15H/ /K7XGLX)X_ST
M],W]GQBVV'.[NH.GCL9%80E?I]J0C!T$6A7 ?H35X\:IN7/9U(^"GW72SM#5
ME,5<$%I990T:WR+3N^6J-E^T.#2J'.ZO!-EI[E5@6+$G@%^=39'F(Y/049F]
M][L4-?@@ $-#U;.)XKU!B]&VZ^+JWO4:E?=6N$ AXZK&0$3U;3O8]X*S_)-.
M0 4W,&E"S.5GE9\Q>Q,G*FB<DM%9D<8)K7D5:LER*=D0A.WP26=54IP#+O0@
MD485Z)!,1AYB$D]+A6.= !]+>L"K),2B0M=D[5%5!&Q97GV0-#92@RG?E]]G
M22C1N&F9VJJ&L40N\3>V!Q^98\A])B[*>U<DSDCT1& ]\<#WW"Z[R#-UC8R?
MT9K/"BP%(AC!M4C(;T&\PVR-D^OVUW/NA'Z+@5O;-EP[%^.5K)-DK!L3?>%A
M3O0RG[A6L[%X>$517&&JQ7JNQ+[3Z#= EGMX:&#D,*ZWT?6'F\D+*7>X+ ZL
MA8\$;&@6-$!6<(K$9BB-M!=+F^T]X',/_C:B&3QJ[4,_&!DC5*U;AD?+RL4K
M8CAOS2L]*5/%EZIYI)+",IVV9O%*8BD>$"[@ OXOGR76/!KXH:-,3&Q/"O.H
M3;H$5R^'2X)EN2+QDVM3:S$6O\&KV%5='HF$Z'9!I@"EN(6J@Z[-1#]<ZL23
MA!["F+)^BI%<!3<&OA= 0\94WC[IJ.E/#XTTHT&#5VHW>B?IOE'I&$QW""BL
MZ 6V=4\;^' W#>L/%17#^5%)_&)Z!8^#-)64A8(WAS2B(7!#;16U_[Z?ZM"1
M)+HBT1AOIJVJ1BD>K.'#S=>,"C(46 8,5O9H#)/P#!34&]:I+VO*R/L,Y$QZ
MWU*+E^XW>([ )(M*P318]TD:(B7!UETE<@>SP*1B2OO<A[5][I7M<Q_6]KE%
MN3.SL-=YY?NAIZ0X&,;P-1LATDR:@'8/D ?(9L:Y&IR2 94S&VY%"W<$2?>5
MTX\'@MN6':*6U9;M#&E:(*A#!O31U;7BT"0,:EE.67]4DABSDQ)_5G%;JK*,
M JKUQAEB6=?6A!AFCK0721]@:><H:8GE![J,@)F5*)LY:V<^]0Q0T3\L V7R
MGYTL?-(0T58R?])JW)!;G4@!(HS[@ &1M!SECILZV#" N,Y*!DH+S*-FN6_S
M2IU!Y:7ON;HMJ)8LKT<.^7JO'.!97"8!XRB'+Z,0Y/?,[&U>4'VS_Y3RJ(_E
M()'4IBM=YH+2V)N+#M4CJ:6>L,N8*^F&VCA()4,,*XQ,1W[D8.S$^G*KJT[D
M A]R!E1;JYFN2>:,H 4J(EG8'<+6MM1$?U0N"M3]56" :I0EUY;TEDU>2QJS
M3]XE6U>+-R [N!3NPI9]24S[>]:<_=TCR9>LVERM4G:$*OI]-0C)_$J^/0/_
M"=*'?QR1">7 #%W-H>]45P40[M&[<BQK]EYQ19'"WB>FUJ.*$*'<@763HH*$
M!6 ]B246PXM3[T58!MCJ4[^H0&EW7+(51\HLJ*NOB![@Z5>D7J->56O<K[2$
MV '(:*D*L#*1X]-*0.OW00]3;'+7]/> OJ_7[B255Y79.<@Z$>\X\)='$9FW
MR;&4E$SI<'>[8!0X4:%GU ;5BV[!4</Z'<'\V6I^?-?<^+&Y&J@IP92FDQK2
M".'0#(6_]3'!%H"^&JBF8X>%PA=IUJ_7'!,2W( 3M0!$+9<J:KF<KZU22!Y%
MHJ/&:>-*(U%KM]7XV *F.$_+TVL"LAR2'>']J R.[SXT=A"*P$A6!9#ED#R]
M;E<&R)V/K0;BXTJ1M92H,R7_T$!] J-(@=2\Z4T;,;6%X@X"NHD%#4!XU+Z[
ME8)ZB=!8K['4J%"8F8MR%J?2.$ZEM^G80;<*VL7"."!0J[8]$57=4.8S*@ T
MC ?])!9*5=;J&=D45(&#DMHE.SOV>[VM4QCYA_4O/.7K".180!>'?+4<_>)A
M>D* G0<B:5&;;0T+?+13^BH^KGT5K^RK^+CV52S*G9F!'+:5S*P\L61@-A@'
M]_SAYB"IV%_;&@T<M'Q3]BA7\(GB@"SO<9B.D%$)PQ1 K#I\87_N44044U9/
M4)7E4@4U)?$MB@XFO5)6H" VR*V&L\,R=S3"<H1.L!9);"OU6B^+0DL%+G 8
MX&,5_AI6FPP\$FB^WV/&39 T%JELD'(?17LO2 <*=5$*JDU \.1HB6B<=CP(
MBQ@%C'*0V6Q^@^K)3%041T5&C\8L9 K$8O",\U-064HR.LJ2 %1*@ .J5+2"
MK$I+=98)0%1H.:F_FNQ-0H.DH4 79%V]OJN*%O_]I;VO8ZR(WH8\[RFIN5_>
MMO?_O?3<>V_-O5^9>^^MN?>\[LQ,2#;]I-.AXQO:KX&!TT^0Q56&]AL%P 0#
MIATRA0S)*$<7"(CS?[QIS0R%-_M_8G77*,!@3N03H9U@VFIO/'NOEG>W':QE
M/,VPQW[<&3A_<HG(/^ MS#BS>;*VUVVL C"6^^@UZ=G=_JUDYT\=$?G?X?A3
M\6B3&?TLT1%RMG<?8+JWX5OKP.N-K:^!.QRZ_46$^'R@/*]16(Q8PVR64<C
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MGMDX$F/8SR8?]D$4>50[ D1I 0=\>6$=^C^MG>T]ZWM_@*_]X<<A'-37@,?
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M#O)PYV+0 I A[.T.:Q'='Y[_ &?9=WJ,2";AHG5S?(YM]6*Z#!0. 6""=70
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MN',';K>BEX&#[P,:P$'!QL(',=*(21OH)5#+[,750+2M._\!]#M\.NP&;H>
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MWLX[,@<*X!DHHF342_/Y%#FT#1&O""2/[(6(NF+!Q&XW&3K(*IV?L&#D/*)
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M-FK=ND&(F<8QB'*6-K?4:TK\@4>DW.,.ATX/E7KK5@P)&QS,:S0M)E+'BP*
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M'*5->DZD;.B):1TC  !+0O6+&HQMTS@\EA:2EX!##9@MWFJVA;8:6E_LN6:
M$44NI6*HRLR9MM9<1V*LAH_$3]KCG6JM00[DH1M%Y >63P+>HQ$&-4_I75;A
M( 94-).4X"$7:.F^Z,G9-U=R:F2^Q_M,PP*X$;0J%!;XOZ^\ AB.W LYZ$U?
M8V$X#5!:Q=@2M%.EPQ@B*E:F0@%+J T"X<E*9!(E1[N7L<ER."(AND2:@J!&
M] YY2  >'0<(VVVA08%)7G< G!0)GM=SNV2*D)N[]?T(Z"'[J@-'VF?(;^2H
M^$PN]1?FYB]5KS-"5/&=DU%W(!NAV)C!K"SFX*_*]/,8 J5/7<LR8=SY'X>#
M(8M=4:M'E=^_(E4V!>-4\'P*"22^F>&=^-F@3A->EM8E]3+A].QDO HB3G+V
M' G=TXDXFHIFIN)6!42\G$--H.)6%40<[N,SJ7A>(WLR#:>,@2<2<:L*&EYF
M@9U,Q*U*:'B]MB;B&Q]>@HC?YF,"R.=@Y'#9IC/&YCAN>&S@B@X@>C2F"J\<
M=D?N!WV6'73'8(%3CCZQ$QV17"S\D#E1O3:?F1A[2:%+HCB+(G8,TQ#\@ TH
M>'WOMG<I= 7NQC >]%598XK>.3DR]$$CEB<)X=DQ0WB*/"QVHONJ@,*D6=9M
M;.1@R T1IXT"GSH+R/P.S"_ 5:'[S!,J-)_^YM7")UZH#)61;R7L,>NQ2N)=
M"UQ:1D@_^VK+8D@?D!05.[)2IPL[QYO?=^ ;C%3BWV@ARB@(?V?\@ @<)3BK
M"L3X76ANG.B<\2+'01^I:&(R$-!9D14/R%$G9CQ/%,E4.'91<+U<O9FR"'!1
M&*LFM[/;"R=@M?0.YHBASH@,=-P!FTY-!E[50E)+*(G$< U'NTAX#N46I?66
M(H,NPYI/8?Y^1:69 !E_50-L/KGHE0RP*<<?$_^5-,!.Z?C;^[5\?#MK']\J
M^O@^OH"HB*XU?V0D0 _$@\V408293'1,G'!O7: \.J"' H&DCMEC%EN@M2-'
MOO>#KF.H$#GCFZRU4&U 2K%)BXFG+-> O9ZF9AT5F_M4-O$LJF(NZ.\!#A+G
MRISR#(>+9N 93W=Q6<@3+^/>"T79I>QG)18PD%=T4FVI.8VRF7K/L;V XC9
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M;&%B+GAM;%!+ 0(4 Q0    ( ,N)9U8T8,YP5P<  ,=8   3
M  "  9H.  !D=BTR,#(S,#,P-E]P<F4N>&UL4$L! A0#%     @ RXEG5O+_
M=)C"$@  4F8  !$              ( !(A8  '1M,C,W-S4Q9#-?.&LN:'1M
M4$L! A0#%     @ RXEG5H%_)X-6I0  (_4# !0              ( !$RD
K '1M,C,W-S4Q9#-?97@Q+3$N:'1M4$L%!@     %  4 0 $  )O.      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
